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Abstract 
T-cell lineage specification and commitment success depends on precise temporal 
induction of T-lineage specific genes, as well as repression of lineage-inappropriate 
programs. After entry into the thymus, T-cell progenitors still retain inherited lineage 
plasticity, reflected by the mixed-lineage pattern of gene expression and the abilities to 
give rise to alternative lineages. Although Notch-Delta signaling is an essential force to 
trigger and sustain T-lineage differentiation, it does not appear to be the only requirement 
for this process. Successful commitment also depends on additional transcription factors, 
which often cooperatively interact with Notch-Delta signaling. However, the molecular 
mechanism by which pro-T cells are advanced to become committed T cells, in particular 
how the alternative lineage potentials are eliminated, is not fully understood. Using the 
genome-wide high-throughput sequencing, we track global shifts in gene expression 
pattern and transcriptional activity associated histone modifications in five successive 
stages of T-cell differentiation that span the commitment process. Our results show that 
T-lineage commitment is defined by the surprisingly complex downregulation of 
progenitor- and/or alternative lineage-associated programs, with relatively few regulatory 
genes are substantially upregulated. Rather than being silenced by a single global 
repression event, progenitor- and/or alternative lineage-associated genes are regulated by 
individual gene-specific mechanisms, indicated by the unsynchronized epigenetic 
transformations at discrete cis-elements of genes loci linked to progenitor and/or 
alternative lineage programs. We also investigate the genome-wide occupancies of PU.1 
and GATA-3, two regulatory factors that have critical but complementary roles in early 
T-cell development. Binding sites choices of these two factors imply that transcriptional 
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regulation by one particular factor is developmental context as well as dosage dependent. 
Furthermore, We combine this genome-wide approach with gene perturbation to study 
the function of Bcl11b, a transcription factor required for the completion of T-cell lineage 
commitment. Our analyses reveal that, in part through directly or indirectly regulation of 
Notch1 and GATA-3, Bcl11b mediates the modulation of T-cell lineage specification and 
commitment.  
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T-cell lineage specification and commitment occur in thymus. Nevertheless, 
committed T cells ultimately derive from hematopoietic stem cells (HSCs), which reside 
in the bone marrow. Rather than through a single step or cell division, this is an 
irreversible journey including multiple distinct successive stages and various fate choice 
decisions a cell has to make. HSCs are rare self-renewing cells, and sit atop a hierarchy of 
all adult blood cell lineage progenitors that become progressively lineage restricted and 
eventually commit to a single blood lineage with specific characteristics (Lai and Kondo, 
2008; Luc et al., 2008; Orkin and Zon, 2008) (Figure 1). T-cell development from 
multipotent self-renewing HSCs is an intertwining process comprising gradual loss of 
self-renewal and disparate lineage potentials, and stepwise activation of T-lineage 
specification program that prepares for the generation of diverse functional T cells in 
periphery. It is achieved without altering DNA sequence, but through coordinative 
activation and repression of subsets of genes that collectively favor T-cell fate over 
others. This process is regulated by various transcription factors that act synergistically or 
antagonistically in response to environmental cues at different stages. The combinatorial 
interactions of these transcription factors are intimately connected with the functions of 
chromatin-modifying enzymes and chromatin-remodeling complexes, which govern the 
accessibility of lineage-specific gene loci and ultimately provide control over the gene 
expression program.  
Any understanding of the molecular mechanism by which T-lineage program is 
installed must take into account the fact that thymic settling progenitors inherit a mixed-
lineage pattern of gene expression and epigenetic structure from previous stages, and 
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therefore the intrathymic development, modulated by a distinct set of regulators, has to 
attain epigenetic switches that eventually confer durable accessibilities at T-cell gene 
loci, as well as permanently silent structures at progenitor-specific gene loci to make 
commitment irreversible. 
Developmental Origins of Hematopoietic Stem Cells 
Establishment and maintenance of blood system relies on the extensive self-
renewal ability and all blood cell lineage differentiation potentials of HSCs. In vertebrate 
embryos, HSCs have been found to arise mainly in two independent anatomic sites, the 
yolk sac (or the ventral blood islands in amphibians), which transiently produces blood 
cell during embryonic stages, and the intraembryonic aorta-gonad mesonephros (AMG) 
region, where fully competent adult-type HSCs are originated (Dzierzak, 1999; Durand 
and Dzierzak, 2005). In addition, large numbers of HSCs have been found in the mouse 
placenta parallel to the emergence of HSCs in AMG (Gekas et al., 2005; Ottersbach and 
Dzierzak, 2005). Subsequently, circulating HSCs migrate to and expand in some 
secondary tissues, such as fetal liver, thymus, spleen, and eventually the bone marrow, 
where they remain throughout adult life. None of these secondary tissues are believed to 
be the founding sites of HSCs, but instead, their niches provide support for long-term 
maintenance of HSCs (Durand and Dzierzak, 2005; Orkin and Zon, 2008). 
From HSCs to Lineage-Restricted Progenitors: A Hierarchical Model of 
Hematopoiesis 
At least eight morphologically and functionally distinct mature blood cell types 
arise from HSCs (Figure 1). Lineage-restricted differentiation from HSCs is a sequential 
and irreversible process, in which alternative lineage choices become increasingly limited 
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(Dzierzak, 1999; Lai and Kondo, 2008; Luc et al., 2008) (Figure 1).  
 
Figure 1. Hierarchical diagram of adult hematopoiesis.  
LT-HSC, long-term hematopoietic stem cell; ST-HSC, long-term hematopoietic stem 
cell; MPP, multipotent progenitor; CMP, common myeloid progenitor; LMPP, lymphoid 
primed multipotent progenitor; MkEP, megakaryocyte/erythroid progenitor; GMP, 
granulocyte/monocyte progenitor; CLP, common lymphoid progenitors; Mk, 
megakaryocyte; E, erythroid; G, granulocyte; M, monocyte (or macrophage); DC, 
dendritic cell; T, T cell; NK, natural killer cell; B, B cell. Curved arrows highlight the 
indefinite or limited self-renewal ability of LT-HSCs (darker arrow) and ST-HSCs 
(lighter arrow), respectively. Some known HSC regulators and lineage-restricting factors 
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(but not limited to) are indicated. Question mark with dashed arrow line indicates the 
relationship remains to be established. 
 
Upon receiving differentiation signals, the first biological response in HSCs is the 
gradual loss of self-renewal ability. Based on the various cell surface markers and the 
ability of maintaining long-term self-renewal characteristics, HSCs can be categorized as 
long-term (LT-) HSCs (CD34-Flt3-Lin-Sca+c-Kit+ (LSK)), which have a lifetime self-
renewal capacity; and short-term (ST-) HSCs (CD34+Flt3-LSK), which are more limited 
in self-renewal and repopulation (Lai and Kondo, 2008; Luc et al., 2008). Upregulation 
of FMS-like tyrosine kinase 3 (Flt3) expression within the LSK compartment marks the 
gradual loss of the self-renewal ability and the transition to multipotent progenitors 
(MPPs, CD34+Flt3loVCAM-1+LSK), which are able to further differentiate into 
megakaryocyte/erythroid (MkE), granulocyte/monocyte (GM) and lymphoid lineage. The 
expression of Flt3 regulates the earliest lymphoid commitment step from HSCs (Sitnicka 
et al., 2002). Compelling evidences show that, under different intrinsic and extrinsic cues, 
MPP (or ST-HSCs) can give rise to either GM-lymphoid restricted lymphoid primed 
multipotent progenitors (LMPPs, CD34+Flt3hiVCAM-1+LSK), which lose the MkE 
potential (Adolfsson et al., 2005), or common myeloid progenitors (CMPs, CD34+Flt3-
VCAM-1+LSK), which have potential for both GM (through granulocyte/monocyte 
progenitors, GMPs) and MkE (through megakaryocyte/erythroid progenitors, MkEPs) 
lineages but not lymphoid lineage (Lai and Kondo, 2008; Luc et al., 2008).  
Within the LMPP compartment, GM-potential decreases with increased lymphoid 
potential, reflected by marked loss of surface expression of VCAM-1. While the most 
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primitive Flt3+VCAM-1+ LSK cells can differentiate into both GM and lymphoid 
lineages, more developmental advanced Flt3+VCAM-1- LSK cells only give rise to 
common lymphoid progenitors (CLPs), precursors for all lymphoid cells including T, B, 
and NK cells (Lai et al., 2005; Lai and Kondo, 2006). 
Temporal- and Stage-Specific Transcription Factors for Hematopoiesis  
Hematopoiesis has long been used as a model system for studying transcriptional 
regulation in lineage differentiation. As ultimate determinants governing cell type-
specific gene expression, transcription factors involved in hematopoiesis are of special 
interest in understanding how HSCs are emerged and maintained, how lineage restriction 
process is programmed, and how genes reflective of diverse hematopoietic lineages are 
regulated (Luc et al., 2008; Orkin and Zon, 2008).  
Unlike embryonic stem cells, HSCs do not have a defined set of core regulators. 
Various HSC specific and general transcription factors have been shown to be required in 
HSCs’ formation, maintenance and function (Figure 1). These factors include the basic 
helix-loop-helix (bHLH) factors SCL/tal1 and Lyl1, the LIM domain-containing protein 
LMO2, the LIM domain-binding protein Lbd1, the SET-domain containing histone 
methyltransferase MLL, runt-domain protein Runx1, zinc finger transcription factor 
GATA-2, Notch1, and several others (Godin and Cumano, 2002; Orkin and Zon, 2008). 
While Mice deficient in any one of SCL/tal1, its associated non-DNA binding partner 
LMO2, or MLL lack both primary (yolk sac) and definitive (AGM or Adult) 
hematopoiesis (Robb et al., 1995; Porcher et al., 1996; Robb et al., 1996; Yamada et al., 
1998; Ernst et al., 2004; Jude et al., 2007), GATA-2, Notch1 and it downstream factor 
Runx1 are each individually important for the specification and expansion of HSCs 
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within AGM, but have less pronounced or no effect on primary hematopoiesis (Tsai et 
al., 1994; Kumano et al., 2003; Burns et al., 2005). The differences in molecular 
regulation imply the possible independent origins between primary and definitive 
hematopoiesis (Godin and Cumano, 2002). On the other hand, the requirement for 
particular transcription factor(s) can be stage specific. For example, although being 
required for the ontogeny of HSCs, SCL/tal1 is no longer necessary for the subsequent 
maintenance or self-renewal of HSCs and multipotent progenitors, and instead becomes 
essential for proper differentiation of erythroid and megakaryocytic precursors (Mikkola 
et al., 2003) (and see below). A closely related bHLH factor Lyl1 is believed to 
compensate the loss of SCL/tal1 in maintaining HSC function (Souroullas et al., 2009). 
Lineage specification and commitment involves fundamental changes of the cell’s 
gene expression program. These changes include induction of genes that confer lineage-
specific function, and repression of genes antagonizing its differentiation. This process 
can be accomplished by the concerted action of general and lineage-restricting 
transcription factors (Figure 1). GATA-1, another GATA family member that is highly 
expressed in megakaryocyte/erythroid progenitors (MEPs) and red blood cell precursors, 
is one of the most critical transcription factors regulating proper erythroid and 
megakaryocyte development. Loss of GATA-1 blocks erythroid development at 
proerythroblast stage, and also leads to defects in megakaryocyte maturation and platelet 
formation, while myeloid and lymphoid development is not affected (Weiss and Orkin, 
1995; Fujiwara et al., 1996; Shivdasani et al., 1997; Vyas et al., 1999). Furthermore, a 
modest decrease in GATA-1 level caused by interruption of an upstream cis-regulatory 
element results in lower efficiency of erythroid maturation (McDevitt et al., 1997). 
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Conversely, PU.1, an ETS family transcription factor, is a multilevel regulator that is 
involved in multiple decision checkpoints in both myeloid lineage and lymphoid lineage 
pathways. PU.1 promotes myelopoiesis at the expense of erythroid/megakaryocyte/ 
eosinophil differentiation in zebrafish (Galloway et al., 2005; Rhodes et al., 2005). 
Conditional deletion of PU.1 in BM leads to a complete loss of CMPs, GMPs, and CLPs, 
but normal or slightly increased MkEPs (Iwasaki and Akashi, 2007). In addition, fate 
choice between macrophage vs. B cell is regulated by the graded expression of PU.1. 
While high levels of PU.1 expression promote macrophage differentiation, low levels of 
PU.1 favor B-cell formation (DeKoter and Singh, 2000). Besides being involved in 
directing macrophage and B-cell differentiation, PU.1 also plays a functionally distinct 
role in early T-cell development (see Chapter 2). It is required for the survival of 
uncommitted pro-T cell, but has to be silent otherwise becomes antagonistic, during or 
immediately after the T-lineage commitment (see below).  
In addition to GATA-1 and PU.1, a variety of lineage-specific transcription 
factors are involved in regulating the specification and commitment of different 
hematopoietic lineages. Acting cooperatively with GATA-1, EKLF (Erythroid Krüppel-
like factor) facilities erythroid lineage commitment and directly upregulates erythroid 
gene expression program (Siatecka and Bieker, 2011), whereas GATA-2 and ETS family 
transcription factor Fli help maintain megakaryocyte identity (Starck et al., 2003; Huang 
et al., 2009). Likewise, along the opposite branch of hematopoiesis, distinct sets of 
transcription factors are required in myeloid and lymphoid lineage pathways. CCAAT 
enhancer-binding protein C/EBPs, including C/EBPα and C/EBPβ, cooperate with PU.1 
in granulocyte/monocyte development in part by directly regulating the expression of 
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many myeloid genes (Friedman, 2002). C/EBPα null mice have normal numbers of 
mature MkE cells and lymphoid, but completely lack granulocytes, a defect that can be 
rescued by inserting C/EBPβ into C/EBPα locus, indicating the essential roles for 
C/EBPs in granulopoiesis (Iwasaki and Akashi, 2007). Moreover, C/EBPα also promotes 
differentiation by limiting HSC self-renewal and repopulating capacity through the 
inhibition of polycomb gene Bmi1(Zhang et al., 2004). 
With respect to lymphoid development, two transcription factors, the Krüppel-
type zinc finger DNA binding protein Ikaros and the bHLH E protein E2A, have been 
shown to be the common regulators for both B- and T-lineage differentiation. While E2A 
is required for LMPP generation from HSCs or MPPs (Dias et al., 2008), LMPPs can 
arise from Ikaros-deficient HSCs or MPPs; however, Ikaros-deficient LMPPs are unable 
to produce B cells, and display reduced T-cell potential (Yoshida et al., 2006; Nutt and 
Kee, 2007). Further restrictions into either B- or T-lineage pathways are achieved by the 
inputs from additional B- or T-lineage specific factors.  
Under B-cell differentiation conditions, E2A first induces the COE family 
transcription factor EBF1 (Early B cell Factor 1). EBF1 and E2A cooperatively promote 
B-lineage specification through upregulation of most B-cell signature genes (Nutt and 
Kee, 2007). One EBF1 target is Pax5, an essential factor for completion of B-lineage 
commitment process. Pax5 not only activates B-lineage specific genes, but, more 
importantly, also represses alternate lineage programs (Cobaleda et al., 2007b). In the 
absence of Pax5, B-cell development is blocked at pro-B cell stage when D-JH 
rearrangement occurs (Nutt et al., 1997). These mutant pro-B cells can grow indefinitely 
in vitro in the presence of IL-7 and stroma, express cell surface receptors MCSF-R 
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(macrophage colony stimulating factor receptor) and Notch, and are capable of 
differentiating into other hematopoietic lineages, such as macrophage and T cell (Nutt et 
al., 1999; Rolink et al., 1999). In addition, Pax5 also upregulates E2A and EBF1, which 
helps amplify B-cell program and conceal its lineage fate (Nutt and Kee, 2007).  
T-lineage specification and commitment, on the other hand, are regulated by 
Notch-Delta signaling and various T-cell-specific or non-T-specific factors, including 
(but not limited to) the high-mobility group (HMG) transcription factor TCF-1, GATA-3, 
Bcl11b, PU.1 and E2A (see below). 
Combinatorial Interactions between Key Regulators Define Hematopoeisis 
As discussed so far, hematopoeisis is regulated by a complex hierarchical system 
involving a considerable number of transcription factors. Orchestration of lineage 
commitment is often modulated by synergistic or antagonistic (competitive or inhibitive) 
protein-protein interactions among different regulators, or by directly transcriptional 
regulation of each other. In HSCs, SCL/tal1, Lmo2 and GATA-2 simultaneously interact 
with a ubiquitously expressed nuclear adaptor Ldb1 to form a transactivating multiprotein 
complex that cooperatively promotes the HSC-specific program (Kim and Bresnick, 
2007; Li et al., 2011). GATA-1, as a central mediator of erythropoiesis, can partner with 
a group of functionally distinct transcription factors including SCL/tal1, Lmo2, FOG1, 
E2A and HEB, EKLF, CBP/p300 and Sp1 to keep erythrocyte development on track 
(Cantor and Orkin, 2002). In particular, SCL/tal1 and its heterodimeric partners E2A and 
HEB have been shown to preferentially cooccupy with GATA-1 at the activated gene 
loci, revealing a molecular mechanism by which GATA-1 distinguishes targets for 
transcriptional activation vs. repression (Yu et al., 2009). Likewise, recent genome-wide 
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binding studies in macrophages and B cells have highlighted the coordinated DNA 
binding between PU.1, a common regulator of macrophage and B-cell differentiation, and 
subsets of lineage-specific transcription factors (for instance, C/EBPs in macrophage or 
E2A and Oct-2 in B cell; see below). Such lineage-specific coordinated binding allows 
PU.1 and its colocalized partners to selectively regulate cell type-specific genes (Heinz et 
al., 2010). Similar context-dependent DNA binding mechanisms have been suggested for 
the stages-specific E2A functions during B-cell development (Lin et al., 2010). 
Besides collaboratively promoting their own lineage differentiation, key lineage 
specific regulators often concurrently antagonize factors associated with disparate 
lineages in a context-dependent manner (Orkin and Zon, 2008). The antagonism can be 
achieved via direct protein-protein inhibition, competition for limiting common cofactors 
to form mutually exclusive protein complex (Siatecka and Bieker, 2011), or 
transcriptional repression. PU.1 and GATA-1 (as well as its close relative GATA-2) 
inhibit each other’s function by direct physical interaction during the myeloid vs. 
erythroid/megakaryocytic fate decision. Enforced expression of PU.1 or GATA-1 in 
multipotent progenitors induce myeloid or erythroid/megakaryocytic lineage 
commitment, respectively. It has been shown that the N-terminal transactivation domain 
of PU.1 can specifically block GATA-1/2 DNA binding activity by interacting with the 
C-terminal zinc-finger of GATA-1/2, which in turn can interfere with PU.1 C-terminal 
ETS domain (Rekhtman et al., 1999; Zhang et al., 1999; Nerlov et al., 2000; Zhang et al., 
2000). GATA-1 also prevents PU.1 from binding to its essential coactivator, c-Jun 
(Zhang et al., 1999). In addition, GATA-1/2 can inhibit PU.1 by transcriptional 
repression through direct binding to the promoter and a -18 kb cis-regulatory element of 
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Sfpi1 (gene that encodes PU.1) (Chou et al., 2009). Additional examples of cross-
antagonism have been described at various bifurcation points of hematopoiesis, including 
EKLF and Fli for erythroid vs. megakaryocyte (Starck et al., 2003), C/EBPα and Pax5 
for macrophage vs. B cell (Xie et al., 2004; Hsu et al., 2006), and Notch1 and Pax5 for T 
vs. B fate decision (Pui et al., 1999; Cobaleda et al., 2007a). With respect to myeloid 
development, although both PU.1 and C/EBPα are required for myeloid lineage 
differentiation, and both are highly expressed within myeloid progenitors and 
synergistically regulate myeloid gene expression, the cell fate choices for granulocyte and 
macrophage are in fact determined by the relative level of C/EBPα and PU.1 in 
granulocyte-macrophage progenitors (Dahl et al., 2003; Laslo et al., 2006). Germline 
deletion of C/EBPα leads to complete abolishment of granulocytes but not macrophage, 
whereas PU.1 deficiency in granulocyte-macrophage progenitors results in excess 
granulocyte production (Zhang et al., 1997; Dakic et al., 2005). The imbalance between 
PU.1 and C/EBPα is amplified through cross-antagonism among secondary cell fate 
determinants comprised of Egr-1,2/Nab-2 and Gfi-1. PU.1 activates Egr-1,2/Nab-2, 
which in turn promote the macrophage program while selectively repressing the 
granulocyte gene expression. Reciprocally, C/EBPα upregulates the granulocyte program 
and represses macrophage genes through the action of Gfi-1(Laslo et al., 2006). This type 
of secondary regulatory circuit has been further elucidated in the context of innate vs. 
adaptive immune cell fates to explain the graded manner of PU.1 in directing macrophage 
and B-cell lineage differentiation (Spooner et al., 2009).  
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Specification and Commitment of T-lineage Program   
Distinct Stages of Early T-cell Developmental 
Unlike most other hematopoietic lineages, T-lineage specification and 
commitment occurs outside of BM in the thymus. The thymus requires perpetual supply 
of hematopoietic progenitors to maintain T-cell development (Foss et al., 2001). 
Although various different BM progenitors are able to give rise to thymocytes if they are 
transferred intrathymically or exposed to permissive conditions in vitro, the precise 
identity of the thymic settling progenitor (TSP) remains exclusive (Zlotoff and 
Bhandoola, 2011). It has been shown the coordinated actions of several membrane 
homing and adhesion molecules are needed for circling progenitors to enter the thymus. 
They include the interaction between P-selectin (expressed by the thymic endothelium) 
and P-selection glycoprotein ligand-1 (PSGL-1; found on subsets of LSKs and CLPs), 
and between thymic-expressed chemokines CCL19/21/25 and two chemokine-receptors 
CCR7/CCR9 (found on subsets of LSKs and CLPs) (Zlotoff and Bhandoola, 2011). It is 
likely that the candidate TSPs express at least one of such surface molecules (PSGL-1, 
CCR7 and CCR9).  
Early T-cell development can be separated into a series of distinct developmental 
stages defined by unique constellations of cell surface markers and/or developmental 
potentials, as well as TCR (T cell receptor) gene recombination (Figure 2). The least 
mature intrathymic progenitors are Lin-c-KithiCD44+CD25- (Lin: CD3, CD4, CD8, 
TCRβ, TCRγδ, CD11b, CD11c, CD19 and NK1.1), and they are termed as ETPs (early 
T-cell precursors), or DN1 (double negative 1; CD4-CD8-) cells. ETPs are very efficient 
in proliferation and can give rise to Lin-c-Kit+CD44+CD25+ DN2 cells. Based on the 
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Figure 2. Landmarks for early T-cell development.  
TSP, thymic-settling progenitor; ETP, early T-cell progenitor; DN, double negative 
(CD4-CD8-); ISP, intermediate single positive; DP, double positive (CD4+CD8+). 
CD4+, CD4 T cell; CD8+, CD8 T cell; M, macrophage; DC, dendritic cell; NK, natural 
killer cell; B, B cell. Space between two black dashed lines represents thymus. 
Differentiation from thymic-settling progenitor to DN3a including β-selection is Notch-
dependent. Commitment occurs during the progression from DN2a to DN2b. Bcl11b is 
required for the completion of T-lineage commitment process, during which progenitor- 
and/or alternative lineage-associated gene programs are permanently silent. 
 
surface expression level of c-Kit, DN2 can be subdivided into earlier c-Kithi DN2a cells 
and later c-Kitint DN2b cells (Yui et al., 2010). With the exception of a rare subset of 
Flt3+CCR9+ ETPs (presumably the most immature intrathymic T-cell precursors) that are 
capable of giving rise to B cell in the absence of Notch signaling (and under B-cell 
permissive condition), majority of ETPs have lost B-cell potential (Rothenberg et al., 
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2008). Nevertheless, both ETP and DN2a cells still retain developmental potentials of 
NK, dendritic cells (DC) and myeloid lineages, although these alternative lineage 
potentials are gradually reduced in DN2a (Bell and Bhandoola, 2008; Rothenberg et al., 
2008; Wada et al., 2008). Lineage commitment occurs as DN2a cells differentiate into 
DN2b cells. This is the first critical checkpoint for T-cell development inside thymus, 
when non-T-fate choices and self-renewal potential are terminated and before extensive 
TCR recombination takes place (Masuda et al., 2007; Yui et al., 2010). DN2b cells 
further downregulate c-Kit and CD44, and become c-KitloCD44-CD25+ DN3 cells. Based 
on cell surface CD27 expression level and cell size, DN3 cells are further subdivided into 
those pre- and immediately post-β-selection (or γδ-selection; DN3a and DN3b, 
respectively). β-selection is another major developmental checkpoint where DN3 cell 
express pre-TCRβ after a successful TCRβ VDJ recombination (Taghon et al., 2006). 
Passing β-selection, cells begin to downregulate CD25 expression and eventually become 
DN4 cells (c-Kitlo/-CD44-CD25-). After DN4 stage, cells start to turn on cell surface 
expression of both CD4 and CD8, and become DP (double positive; CD4+CD8+) cells. 
DP cells ultimately acquire TCRαβ complex, which prepares cells for the positive 
selection and negative selection to generate mature CD4 or CD8 SP (single positive) T 
cells (Rothenberg et al., 2008). 
Notch-Delta Signaling Regulates Early T-cell Development  
Thymic epithelial cells supply various ligands, growth factors and cytokines that 
are required for T-cell differentiation, proliferation, and survival. Among them, arguably 
the most important one is Delta-like 4, the ligand for the T-cell surface receptor Notch1. 
For normal T-cell development to occur, potential T-cell progenitors must be able to 
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response to Notch signaling after entering the thymus (Sambandam et al., 2005). Notch-
Delta interaction initiates a cascade of proteolytic reactions that liberate Notch 
intracellular domain (NICD). The NICD then translocates into the nucleus and 
heteodimerizes with transcription factor CSL (RBP-J). This binding converts CSL from a 
repressor to a activator, and subsequently activates the expression of target genes 
(Yashiro-Ohtani et al., 2010). Notch-Delta signaling is an essential driving force during 
early stages of T-cell development up to and including β-selection (or γδ-selection). 
Upon successful β-selection, though being continuously active, Notch-Delta signaling 
becomes dispensable for the rest of maturation process (Rothenberg et al., 2008; Yashiro-
Ohtani et al., 2010). Notch signaling promotes T-lineage specification and inhibits the 
alternative lineage potentials in pro-T cells. It has been shown that overexpression or 
constitutive activation of Notch signaling in bone marrow progenitors promotes thymic-
independent T-cell formation at the expense of B-cell development, while deletion or 
inhibition of Notch in progenitors or DN1 cells abolishes T-cell development and results 
in vastly increased intrathymic B cells and dendritic cells (Feyerabend et al., 2009; 
Yashiro-Ohtani et al., 2010). At the moment, the mechanism by which the B-lineage 
potential is repressed by Notch1 remains unclear. A closely related question is whether 
additional factors other than Notch1 are also required to keep pro-T cells on track from 
converting into B cells, since B cells can no longer arise from CD25+ DN2a or DN2b 
cells even if Notch signaling is inactivated (Schmitt et al., 2004; Sambandam et al., 2005; 
Feyerabend et al., 2009). 
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Additional Essential Regulators for Early T-cell Development 
Notch1 is not a T-lineage specific regulator; rather, it is a multilevel factor 
involved in various aspects of embryonic development. In order to launch a T-specific 
program, Notch signaling has to collaborate with many other regulators (Rothenberg et 
al., 2008). One such factor is E2A. E2A is expressed at constantly high level throughout 
early T-cell development (see Chapter 2). As discussed earlier, E2A is a common 
regulator for both B- and T-lineage development. E2A deficiency causes a partial arrest 
at the DN1 stage and leads to T-cell lymphomas at very young age (Bain et al., 1997). 
Retroviral infection of E2A-deficient fetal liver precursors with NICD recues the 
developmental block (Ikawa et al., 2006). The presence of CSL-preferred binding sites 
and neighboring bHLH A protein binding sites has been suggested to be the minimal 
DNA code necessary and sufficient to drive Notch signaling mediated gene activation 
(Cave et al., 2005), which may in turn help E2A selectively target T-cell genes instead of 
B-cell genes. Further characterizations uncovered that E47 (a splicing isoform of E2A 
gene) is directly involved in activating a group of genes known to be Notch1 targets, 
including Hes1, Hes5, Ptcra and Notch3 (Ikawa et al., 2006). Taken together, these 
findings suggest that E2A acts synergistically with Notch signaling to modulate T-lineage 
differentiation. 
Another multilineage regulator that is required for early T-cell development is 
PU.1. PU.1 is highly expressed in prethymic mulitpotent progenitors as well as DN1 
cells, and is slightly reduced but still at considerable level in DN2a cells. It is rapidly 
downregulated during commitment, and essentially undetectable before β-selection (Nutt 
et al., 2005; Tydell et al., 2007) (see Chapter 2). PU.1 is required for generating thymic 
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settling progenitors, and PU.1 deficiency leads to a developmental block at DN1-like 
stage (Scott et al., 1994; Spain et al., 1999; Dakic et al., 2005). We have shown that PU.1 
global occupancy pattern in DN1 (and DN2a) cells is significantly distinct from that in B 
cell or macrophage, implying PU.1 DNA binding is lineage specific. Furthermore, a 
substantial percentage of PU.1 targets are either upregulated or stably expressed in pro-T 
cells, including many T-cell identity genes (see Chapter 2). These observations 
collectively suggest that PU.1 may positively regulate T-cell specification during early 
stages of development. On the other hand, PU.1 downregulation is a prerequisite for the 
T-lineage commitment; PU.1 antagonizes T-cell development if expressed constitutively 
in DN2b or DN3 cells (Anderson et al., 2002). Enforced expression of PU.1 in pro-T 
cells reduces Hes1 and c-Myb mRNA level, suggesting an antagonistic function of PU.1 
imposed on Notch-Delta signaling (Anderson et al., 2002). Moreover, exogenous PU.1, 
either by itself or in collaboration with exogenous C/EBPα, is capable of reprograming 
committed DN3 cells into myeloid fate, and this process can be blocked, at least partially, 
by Notch-Delta signaling (Franco et al., 2006; Laiosa et al., 2006). Thus, during early 
stages of T-cell development PU.1 may “negotiate” with Notch1 and other factors in 
establishing a balance between promoting T-lineage specification and at the same time 
preserving some non-T-cell potentials (Rothenberg, 2007).  
Among the core group of T-lineage regulatory factors, TCF-1, GATA-3 and 
Bcl11b are the few factors that are expressed in a seemingly T-lineage-specific manner 
(Rothenberg et al., 2010). Besides to Notch1, TCF-1 is the only other identified factor 
that can specifically direct bone marrow progenitors into the T-lineage pathway (Weber 
et al., 2011). TCF-1 is turned on at a substantial level in the earliest DN1 cells. Its 
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expression moderately increases from DN1 to DN2a, and stays steady afterward (see 
Chapter 2). TCF-1 is indispensable for T-lineage specification. Recently, it has been 
shown to be a downstream mediator of Notch signaling, and, if ectopically expressed in 
bone marrow LMPP, be able to promote T-cell development in the absence of Notch 
signaling (Weber et al., 2011). TCF-1 directly upregulates a group of T-cell identity 
genes involved in TCR complex assembly and signaling components, including Lck, 
Cd3g/d/e, Lat and Rag2. However, without Notch-Delta signaling, TCF-1-expression 
precursors only give rise to DN2/3-like cell, and fail to induce Dtx1 and Ptcra, two 
known Notch1 targets, the latter one of which is an essential component of pre-TCRβ 
complex (Weber et al., 2011). Thus, a TCF-1-indenpendent Notch pathway is also 
required for the completion of T-cell specification. 
Similar to TCF-1, GATA-3 is among the earliest factors induced by Notch 
signaling in T-cell precursors (Taghon et al., 2005). It is the only GATA factor that is T-
lineage specific and is required recurrently during many stages of T-cell development. It 
is essential for the whole T-lineage commitment process from DN1 stage and onward. 
GATA-3 is also the main driving force in generating peripheral T helper 2 (Th2) cell and 
maintaining its polarized immune response (Paul and Zhu, 2010). Compared to that in 
Th2 cell, GATA-3 expression in early stages (i.e., DN1 to DN3) of T-cell development is 
relatively low and rather stable (within 2~4x change, see Chapter 2). Genome-wide DNA 
binding studies reveal that GATA-3 binds to a number of T-cell identity genes, 
implicating its role in T-lineage specification (Wei et al., 2011) (see Chapter 2). GATA-3 
function in early T-cell development has been shown to be context- and dosage-
dependent. GATA-3-deficient embryonic stem cells can contribute to the development of 
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mature erythroid, myeloid and B-lineages, but fail to give rise to T-lineage (Ting et al., 
1996). Paradoxically, rather than promoting developmental progression, overexpression 
of GATA-3 in the DN2a stage either blocks cell survival when Notch-Delta signaling is 
activated, or diverts differentiation program into mast cell pathway under non-T-cell 
permissive condition (Taghon et al., 2007). 
In addition to the activation of a specification program for T-cell identity genes 
and transcription factors that regulate these genes, to become a committed T cell, T-cell 
precursors must concurrently repress genes associated with progenitor or/and alternative 
lineages, including abovementioned PU.1. Compelling evidence has shown that these two 
seemingly related processes are regulated by separate mechanisms (Rothenberg et al., 
2010). One regulator functionally implicated to play an essential role in the latter process 
is Bcl11b. Bcl11b is a Krüppel-like C2H2 type zinc finger transcription factor, and is 
exclusively expressed in T-lineage of all hematopoietic lineages. It is absent in ETPs, and 
first turns on at relatively low level in DN2a cells. Bcl11b is among very few 
transcription factors that are strongly upregulated (>50×) during the commitment from 
DN2a to DN2b, and is then maintained at similar level throughout T-cell development (Li 
et al., 2010b) (see Chapter 2). Conditional deletion of Bcl11b in T-lineage progenitors 
arrests cells at DN2a-like (c-KithiCD44+CD25+) stage with increased alternative lineage 
potentials, in particular NK potential, that are less sensitive to the Notch1 inhibition 
(Ikawa et al., 2010; Li et al., 2010a; Li et al., 2010b). Unlike GATA-3, Bcl11b is not 
required for the survival or proliferation of DN2a cells; Bcl11b deficient DN2a-like cells 
can sustain growth with Notch-Delta signaling and cytokines for weeks in vitro. And in 
contrast to the failure of making αβ T cells, Bcl11b deficient cells are able to give rise to 
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γδ T cells (Wakabayashi et al., 2003; Li et al., 2010a). Gene expression profiling 
indicates that Bcl11b-deficient DN2a-like cells upregulate NK-lineage signature factors, 
including Id2, Zbtb16, Nfil3 and Il2rβ even before these cells actually differentiate into 
NK-like cells (Li et al., 2010a; Li et al., 2010b) (see Chapter 3). Since some of these 
genes, such as Il2rb, are normally kept silent even before Bcl11b is induced, they may 
not directly repressed by Bcl11b or repressed by other mechanisms when Bcl11b is 
absent (Rothenberg et al., 2010). In addition to NK lineage, Bcl11b-deficient cells also 
fail to completely silence some myeloid and DC lineage as well as progenitor specific 
genes (Li et al., 2010a).  
In summary, as a branch of hematopoeisis, T-cell development in thymus is 
defined by a progression of phenotypically well-characterized stages. And this process is 
achieved by deploying a battery of T-lineage specific and non-specific transcription 
factors to stepwise induce T-cell identity genes and gradually eliminate alterative lineage 
potentials. 
Multilineage Priming and Lineage Plasticity  
Using single-cell expression profiling and genetically marked lineage-restricted 
transcription reporters, such as GATA-1-GFP, PU.1-GFP, Ikaros-GFP, Lysozyme-YFP 
and Rag1-GFP, researchers have been able to trace the onset and dynamics of lineage-
restricted genes during lineage commitment process (Luc et al., 2008; Orkin and Zon, 
2008). These studies showed that although majority of lineage-restricting transcription 
factors or lineage-determinants display lineage-specific expression patterns that mirror 
the hierarchy diagram of hematopoiesis, such as GATA-1 in megakaryocyte/erythroid 
progenitors (MEPs) and red blood cell precursors, and PU.1 and C/EBPα in myeloid 
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lineage, many of them are also “promiscuously” coexpressed, albeit at low level, within 
HSCs and MPPs prior to differentiation ⎯ a phenomenon termed lineage-priming (Hu et 
al., 1997; Miyamoto et al., 2002; Ye et al., 2003; Adolfsson et al., 2005; Nutt et al., 2005; 
Arinobu et al., 2007; Mansson et al., 2007; Ng et al., 2009). Lineage-priming has been 
suggested to reflect the coexisting developmental potentials in HSCs and MPPs, and 
provide a framework for “crosstalk(s)” between individual lineage potentials in response 
to different environmental cues (Orkin and Zon, 2008). In HSCs or MPPs, the 
antagonistic interplays between diverse lineage-affiliated transcription factors are 
balanced, keeping opposing factors at levels that are too low to elicit lineage 
differentiation. During differentiation, triggered by extrinsic or intrinsic signals, this 
balance tilts toward favoring one particular lineage pathway, which resolves the mixed-
lineage pattern of gene expression and subsequently propagates the lineage-specific 
program (Laslo et al., 2006; Ng et al., 2009). 
Mixed-lineage patterns of gene expression are also common phenomena in 
uncommitted precursors, revealing the inherited developmental plasticity before 
alternative lineage potentials are completely lost (Yoshida et al., 2010) (see Chapter 2). 
Lineage commitment has long been considered irreversible under physiological 
conditions. However, instead of being “hit-and-run” factors, several lineage-committing 
regulators (with the loose exception of Notch1), such as GATA-1, Pax5, C/EBPα and 
Bcl11b, are continuously present after commitment or sometimes even in terminally 
differentiated cells. Several studies have found that alteration of a single or a few 
regulatory factors can “de-commit” lineage committed cells back to uncommitted state, 
or reprogram committed cells to another cell fate (Kulessa et al., 1995; Xie et al., 2004; 
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Franco et al., 2006; Laiosa et al., 2006; Cobaleda et al., 2007a; Li et al., 2010b). Taken 
together, these studies suggest that commitment may actually be more flexible than 
previously thought. It also suggests that, even in lineage committed cells, the regulatory 
pathways promoting disparate lineages have to be permanently maintained in silent state 
by specific lineage-committing factors or by epigenetic modifications (Orkin, 2003). 
Epigenetic Modifications and Lineage Differentiation 
Through the collective functions of DNA binding regulators and chromatin-
modifying enzymes and chromatin-remodeling complexes, external signaling is 
converted into epigenetic information that often has profound influence on gene 
expression and cell fate determination. Changes in epigenetic modifications, including 
histone modifications and DNA methylation, may alter DNA accessibility of 
transcription factors’ target sites, therefore, together with the availability of lineage/stage 
specific transcription factors control cell type-specific transcription programme (Schones 
and Zhao, 2008). 
While majority of CpG dinucleotides are cytosine methylated, CpG islands, often 
localized at the promoter regions of many genes, are more resistant to methylation. In 
HSCs or MPPs, CpG island methylation largely occurs at lineage-restricted gene loci to 
maintain their long-term stable repression and prevent premature differentiation. Upon 
lineage differentiation, these loci undergo lineage-restricted demethylation, while, 
reciprocally, DNA methylation starts to build up at the CpG islands of some stem-cell 
self-renewal- and/or disparate lineage-associated genes loci (Borgel et al., 2010; Hawkins 
et al., 2010; Ji et al., 2010; Cedar and Bergman, 2011). In contrast, histone proteins are 
subject to numerous types of reversible covalent posttranslational modifications, 
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including acetylation, methylation, phosphorylation and ubiquitination, primarily at the 
N-terminal tails. Lysine acetylation and methylation are the most studied and better-
understood modifications. While lysine acetylation, such as H3K(9,14)Ac, H3K27Ac and 
H4K16Ac are considered as hallmarks of active or accessible chromatin and 
transcriptional activity, lysine methylation can have different, sometimes completely 
opposite, biological effects depending on which residue is modified. Methylation of 
H3K36 is associated with transcribed chromatin, and methylation of H3K4 is linked to 
active or accessible chromatin (H3K4me3/2), or poised chromatin state (H3K4me2/1). 
On the other hand, methylation of H3K9, H3K27 and H4K20 has been implicated to 
associate with heterochromatic domains and transcriptional repression (Schones and 
Zhao, 2008). Many DNA-sequence specific transcription regulators also contain 
functional domains that recognize different modified histones or methylated CpG (Martin 
and Zhang, 2005; Cedar and Bergman, 2011). Thus, besides regulating the accessibility 
of sequence-specific DNA target sites, modified (or de-modified) histones and/or 
methylated CpG islands can act as docking sites for some transcription factors, thereby 
allowing them to engage chromatinized targets, or in some cases preventing other DNA 
binding factors from binding to their target sites and causing unregulated gene activation 
(Martin and Zhang, 2005; Cedar and Bergman, 2011). 
Many hematopoietic regulators have been implicated to associate with or possibly 
even direct chromatin-modifying enzymes and chromatin-remodeling complexes in 
establishing stem cell or lineage-specific epigenetic landscapes. For instance, in HSCs, 
members of PRC1 (polycomb repression complex 1), such as Bmi1, Mel18 and Rae28, 
appear to specifically silence genes that are involved in apoptosis, senescence, and 
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differentiation, thereby regulating stem cell self-renewal and maintenance (Akala and 
Clarke, 2006).	   (However, since it is the PRC2 component histone methyltransferase 
EZH2 that catalyzes the trimethylation of H3K27, which in turn recruits PRC1, it remains 
unclear how EZH2 recognizes specific targets in the first place (Cedar and Bergman, 
2011)) As discussed earlier, GATA-1 physically interacts with CBP/p300 to recruit HAT 
(histone acetyltransferases) activity to erythroid-specific gene loci during erythroid 
development, and thereby facilitating their expression (Cantor and Orkin, 2002). FOG-1, 
another factor associated with GATA-1 (as well as GATA-2), can bind to CtBP 
(corepressors C-terminal-binding protein) and the NuRD (nucleosome remodeling and 
deacetylase) complex, which may selectively mediate GATA-1 linked repression and 
chromatin remodeling (Kim and Bresnick, 2007). Ikaros, a key regulator for lymphoid 
development, has been shown to directly associate with two chromatin remodeling 
complexes, the NuRD and the SWI-SNF complex in both T cells and erythroid 
progenitors (Ng et al., 2007). It is likely that by selectively altering the accessibility of 
target gene loci, Ikaros restricts erythroid and/or myeloid-specific programs while 
promoting lymphoid development (Ng et al., 2007). Through the conserved SNAG 
domain, Zinc-finger repressors Gfi-1 and Gfi-1b, which respectively play important roles 
in myelolymphoid development or erythroid and megakaryocytic development, recruits 
HDACs (histone deacetylases) 1 and 2, CoREST (REST corepressor), and the histone 
demethlyase LSD1 to their binding sites, leading to the silencing of relevant target genes 
(Saleque et al., 2007). Interestingly, depending on its partners, LSD1 can act as a 
repressor or activator by demethylating methylated H3K4 or H3K9, respectively 
(Metzger et al., 2005; Garcia-Bassets et al., 2007; Wang et al., 2007). Within Gfi-1/1b 
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mediated multiprotein complex, LSD1 apparently only affects methylated H3K4, 
suggesting the repression guided by the Gfi proteins is context-dependent (Saleque et al., 
2007). In T cells, prior to Notch activation, the DNA binding transcription factor CSL 
acts as transcriptional repressor through interaction with a corepressor complex 
containing HDAC-1, SMRT (silencing mediator of retinoid and thyroid hormone 
receptor) and MINT (Msx2-interacting nuclear target protein), which can in turn recruit 
CtBP corepressor (Kao et al., 1998; Oswald et al., 2005). Ligand activation of Notch 
induces the liberation and subsequent nuclear translocation of NICD. NICD displaces 
corepressors and heterodimerizes with CSL, therefore converting the whole complex into 
a transcriptional activator. Once bound to CSL, NICD recruits MAML1 (Mastermind-like 
1), which in turn interacts with CBP/p300 and lysine acetyltransferases (HATs) PCAF 
and GCN5 to modulate transcription of specific targets (Kurooka and Honjo, 2000; 
Wallberg et al., 2002). Finally, Bcl11b has been biochemically implicated to directly 
interact with the NuRD complex through its N-terminal domain to repress target sites, 
consistent with its largely repressive function during T-cell development (Cismasiu et al., 
2005; Ikawa et al., 2010; Li et al., 2010a; Li et al., 2010b) (see Chapter 3). 
Thus, by modifying cis-regulatory elements, epigenetic modifications stabilize the 
effects of developmentally controlled trans-activators (Cedar and Bergman, 2011). 
Recent genome-wide analyses have demonstrated that temporal and spatial variations of 
histone modifications are closely linked with developmentally regulated genes (Bernstein 
et al., 2005; Mikkelsen et al., 2007; Orford et al., 2008; Araki et al., 2009; Wei et al., 
2009; Hawkins et al., 2010; Weishaupt et al., 2010; Koche et al., 2011). The coordination 
of lineage-specific expression during development is often preceded by the programmed 
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changes in epigenetic marking. Several lineage-determining transcription factors, 
including (not limited to) GATA-1, PU.1, E2A and EBF1, have been suggested to be able 
to induce chromatin remodeling (often at modest level) through the recruitment of 
methyltransferases. Methyltransferases mono- or di-methylate H3K4 of genomic regions 
flanking the respective transcription factor binding sites, which often contain a mixture of 
closely spaced DNA binding sites that are specific to small sets of other lineage-
determining transcription factors (Cheng et al., 2009; Heinz et al., 2010; Lin et al., 2010; 
Treiber et al., 2010). Mono- or di-methylated H3K4 (H3K4me or H3K4me2) makes 
chromatins accessible to those secondary lineage-determining factors, which in turn 
facilitate more H3K4 methylation and/or H3/H4 acetylation to eventually entail a 
lineage-permissive epigenetic landscape available to more lineage-specific or general 
transcription factors. In addition, collaborative DNA binding of different transcription 
factors within a short distance may stabilize their binding. Therefore, through epigenetic 
marking a small set of lineage-determining transcription factors acting in concert initiate 
and propagate lineage-specific gene program (Heinz et al., 2010; Lin et al., 2010). 
In HSC or progenitors, opposing histone modifications (e.g. H3K27m3 and 
H3K4me3) can be found to coexist “bivalently” at the same gene locus. Upon 
differentiation, such “bivalency” often resolves in subsequent stages with “bivalent” sites 
either to become activated by shedding H3K27me3, or reciprocally to be repressed by 
losing H3K4me3 and/or adding more H3K27me3 (Bernstein et al., 2005; Barski et al., 
2007; Mikkelsen et al., 2007; Cui et al., 2009). In addition, it has been shown that 
developmentally poised genes are more likely enriched with H3K4me2 (Attema et al., 
2007; Maes et al., 2008; Orford et al., 2008; Koche et al., 2011) (see Chapter 2). These 
	   28	  
observations suggest that H3K4me2/3 marking may serve as a flexible platform for future 
lineage specification programming (Cedar and Bergman, 2011). One possible effect of 
lineage-priming (or mixed-lineage gene expression) is to keep chromatins accessible for a 
broad spectrum of lineage-determining factors through H3K4me2 marking. This 
permissive chromatin structure becomes progressively lineage-restricted as HSCs or 
MPPs differentiates (Attema et al., 2007; Maes et al., 2008). For example, although both 
Gata1 and Gata3 are expressed at low or background level in HSCs and MPPs, they are 
both enriched with H3K4me2 at their promoters. Gata1 promoter gains more H3K4me2 
and H3K4me3 in the MEPs, where Gata1 expression is upregulated, and becomes 
demethylated in the CLPs, in which Gata1 is repressed (marked by H3K27me3). The 
opposite is true for Gata3 (Attema et al., 2007). The existing of permissive chromatin 
structure can be further confirmed by the finding that ectopically expressed EBF1 is able 
to bind to some B cell-specific gene loci without inducing expression in a non-B 
hematopoietic cellular context (committed T cells), but fails to do so in a non-
hematopoietic context (NIH 3T3 cells) (Treiber et al., 2010). Furthermore, EBF1 is 
unable to bind to know adipocyte- or neuronal-specific target genes in pro-B cells 
(Treiber et al., 2010). One possible explanation is that T cells (or B cells) inherit the 
hematopoietic specific permissive chromatin structure from progenitors (epigenetic 
memory). However, since B- and T-lineage share several common factors, such as E2A, 
coordinate EBF1 and E2A (or others) binding may occur when EBF1 is ectopically 
expressed in T cells (Treiber et al., 2010). It would be informative to investigate whether 
EBF1 can bind to B cell-specific gene loci in another hematopoietic context, such as 
committed erythroid cells, which are developmentally more remote than T cells. 
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Nevertheless, all abovementioned studies suggest that the epigenetic marking plays an 
important role in modulating lineage differentiation program. 
Theme of Thesis 
As discussed earlier, multiple T-lineage specific and non-T-lineage specific 
transcription factors are involved in the regulation of T-cell lineage specification and 
commitment. The roles that individual factors play during early T-cell development have 
been the subjects of intensive studies. However, one largely unsolved problem is how T-
specific and non-T-specific factors act cooperatively to construct a gene regulatory 
network that is T-lineage specific. The major roadblock to answer this question is that 
very few T-lineage specific cis-regulatory elements have been identified. 
In Chapter 2, I present that, using genome-wide approaches, we mapped 
developmentally dynamic histone modification sites, and their linked gene expression. 
Our study provides a new way to locate potential cis-regulatory elements that translate 
and stabilize distinct trans-regulatory inputs. I also show that many genes associated with 
lineage plasticity in pro-T cell are actively repressed by individual gene-specific 
mechanisms. Furthermore, I show that two essential regulators, PU.1 and GATA-3, 
exercise their functions in lineage/stage specific manners. In Chapter 3, I summarize an 
ongoing project about Bcl11b’s role during T-cell lineage commitment, which I 
collaborate on with Dr. Long Li. Using a gene perturbation approach combined with the 
genome-wide analyses, we profiled global gene expression pattern and GATA-3 
occupancy in Bcl11b-deficient cells. Our finding suggests that Bcl11b connects T-lineage 
specification and commitment partially through properly regulating Gata3 and Notch1. 
Finally, Chapter 4 concludes with a brief discussion of some implicates from the studies 
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described herein. 
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Dynamic Transformations of Epigenetic Marking and Genome-
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Abstract 
T-cell development comprises a stepwise process of commitment from a multipotent 
precursor. To define molecular mechanisms controlling this progression, we probed five 
stages spanning the commitment process using RNA-seq and ChIP-seq to track genome-
wide shifts in transcription, cohorts of active transcription factor genes, histone 
modifications at diverse classes of cis-regulatory elements, and binding repertoire of 
GATA-3 and PU.1, transcription factors with complementary roles in T-cell 
development. The results highlight potential promoter-distal cis-regulatory elements in 
play and reveal both activation sites and diverse mechanisms of repression that silence 
genes used in alternative lineages. Histone marking is dynamic and reversible, and while 
permissive marks anticipate, repressive marks often lag behind changes in transcription. 
In vivo binding of PU.1 and GATA-3 relative to epigenetic marking reveals distinctive, 
factor-specific rules for recruitment of these crucial transcription factors to different 
subsets of their potential sites, dependent on dose and developmental context. 
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INTRODUCTION 
T-lymphocyte development illuminates the sequential process of cell fate choice 
for descendants of multipotent stem cells. Notch pathway signaling in the thymus causes 
hematopoietic precursors to become committed to the T-cell fate, while mobilizing a T-
cell gene expression program that prepares the cells for T-cell antigen receptor (TCR) 
expression, TCR-based repertoire selection, and long, versatile careers as immune 
effectors. Sequential events that exclude alternative lineages occur at phenotypically 
well-defined stages within the thymus, providing a revealing model for the kinds of 
events needed to channel multipotent stem cells into a single developmental path 
(Rothenberg, 2011; Yang et al., 2010). However, major questions about the molecular 
mechanisms involved in this process have remained.  
One question is how commitment works. Most of the alternatives to T-cell 
differentiation that are initially open to the precursors depend on the action of dominant 
transcriptional regulators, such as PU.1 (and C/EBPα) for myeloid and dendritic cells, 
and EBF1 and Pax5 for B cells. Although these genes are either expressed or inducible in 
the precursors entering the thymus, they end up not only repressed but irreversibly 
silenced as a result of commitment. The mechanisms responsible for these regulatory 
changes have been unknown.  
Another question has been how the T-cell program is deployed. Notch signaling, 
triggered by ligands in the thymic microenvironment, is crucial to initiate and sustain 
differentiation. T-cell development also depends on additional transcription factors, 
including basic helix-loop-helix E protein dimers (E2A and HEB), the high mobility-
group factors TCF-1 and LEF-1, GATA-3, Myb, Runx1, Ikaros, and Gfi1 (Rothenberg et 
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al., 2008). However, it is not clear if these are all the factors involved. Exactly what their 
roles are in establishing T-cell identity remains particularly obscure because so few T-cell 
specific cis-regulatory elements have been identified. Consequently, almost none have 
been functionally dissected in enough detail to explain the expression of the genes they 
control in terms of their specific and complete regulatory inputs.  
For other hematopoietic cell types where known lineage-specific factors 
positively confer cell identity, key cis-regulatory sequences of developmental genes have 
been identified through the collaborative binding of these factors. For example, combined 
binding sites of E2A, EBF1, and/or Pax5 are target cis-regulatory elements used in the B-
cell program (Lin et al., 2010; Schebesta et al., 2007). PU.1 binding, with various partner 
factors, has been a useful probe to detect myeloid cis-elements (Ghisletti et al., 2010; 
Heinz et al., 2010). In contrast, for T cells, nearly all the transcription factors known to be 
required are also required by other hematopoietic lineages (Rothenberg and Scripture-
Adams, 2008). Thus, no formula known a priori is useful to define T-lineage specific cis-
regulatory elements. However, it is possible to work in the opposite direction. If the cis-
regulatory elements that are “in play” at crucial transitions of T-cell development can be 
defined globally, then the motifs enriched in these elements could be matched with the 
cognate transcription factors that also change at those stages, thus narrowing the search 
for the key factors controlling commitment (Novershtern et al., 2011).  
Here we identify the dynamic transformations in transcription and epigenetic 
marking that occur across the genome through five successive stages of T-cell 
differentiation that span lineage commitment. The results provide a genome-wide view of 
a lineage choice process in unusually fine resolution. To test the functional relevance of 
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the histone marking patterns at potential proximal and distal cis-regulatory elements, we 
also track in vivo binding of GATA-3 and PU.1, two transcription factors previously 
shown to have complementary, dose-dependent and context dependent roles in these 
stages of T-cell development (Rothenberg and Scripture-Adams, 2008). Site selection 
rules for these two factors are revealed to be context-dependent but differently affected 
by dose. The results provide evidence for an actively sustained regulatory phase 
dominated by stem/ progenitor-cell regulatory genes that initially persists under Notch 
signaling, then is dismantled to establish T-cell identity. 
 
RESULTS 
Strategy for Analysis of T-lineage Commitment 
Our goals were first, to map comprehensively the genes that undergo 
transcriptional change during T-lineage choice, especially genes encoding transcription 
factors; and second, to locate likely cis-regulatory sites mediating these gene expression 
changes by defining regions where histone marks are altered at each step of the process. 
RNA analysis by deep sequencing (RNA-seq) was used to measure changes in global 
transcriptional activity (Mortazavi et al., 2008), while chromatin immune precipitation 
and deep sequencing (ChIP-seq) monitored the changing distributions of histone marks 
across the genome in parallel (Wold and Myers, 2008). 
In mice, the earliest stages of T-cell differentiation represent only a minuscule 
fraction of thymocytes present at steady state (Petrie and Zuniga-Pflucker, 2007). Cells 
from the first major stage, “early T-cell precursors” or Kithigh DN1 cells (Kit++ CD44+ 
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CD25- and CD4- CD8- TCR-“double negative”), proliferate as they pass through the 
“DN2a” stage (Kit++ CD44+ CD25+) to the “DN2b” stage (Kit+ CD44+ CD25+), when 
they undergo T-lineage commitment. Post-commitment, they accumulate in the “DN3” 
stage (Kitlow CD44low CD25+), and slow their cycling to allow rearrangement of the TCR 
genes and create a checkpoint for TCR rearrangement success. Only cells that 
successfully express TCR proteins proliferate again, differentiating to the “DP” stage 
(CD25- CD4+ CD8+). Cells are selected after this based on their TCR recognition 
specificity, and further differentiation refines their mature immunological roles. 
However, all pre-commitment cells together represent only 0.1% of the cells in a 
thymus. To obtain large numbers of the earliest cells, we therefore used an in vitro 
differentiation system that generates copious yields of early T-cell precursors from fetal 
liver (FL)-derived hematopoietic progenitor cells. These precursors are co-cultured with 
lymphoid-permissive cytokines and OP9 stromal cells expressing a Delta-like Notch 
ligand (OP9-DL1). In these conditions a cohort of Kithigh DN1 (FLDN1) and FLDN2a 
cells is generated by day 4.5 of culture, mostly progressing to DN2b cells by day 8.5 
(FLDN2b, Figure S1A). As an in vivo counterpart, we also purified slightly more 
advanced DN3 stage cells from freshly isolated adult mouse thymus, and to evaluate 
changes that follow after commitment, DP thymocytes were also purified (ThyDN3, 
ThyDP) (Figure S1B, C, see Supplemental Methods). In vitro differentiated FL-derived 
DN1 and DN2 cells showed gene expression well matched to that of normal in vivo 
thymocyte counterparts, based on previous analyses of adult thymocyte gene expression 
(Yui et al., 2010; David-Fung et al., 2009; Kawazu et al., 2007; Tabrizifard et al., 2004) 
(http://www.immgen.org (Heng et al., 2008)). Their lineage commitment status was also 
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in good agreement with that of in vivo counterparts (Table S1). FLDN1 cells after 4.5 
days of culture with OP9-DL1 cells could still generate NK, myeloid or dendritic cells, 
and even some B cells if shifted to non-T conditions (OP9-control co-culture), whereas 
FLDN2a cells mostly generated NK cells under these conditions and FLDN2b cells could 
not generate any alternative cell types (Table S1). Some details of lineage exclusion 
timing were slightly shifted from those in corresponding steady-state adult thymocytes 
(Rothenberg, 2011) (see Table S1 legend), but the discontinuity between these DN2a and 
DN2b subsets was as clear as for populations from normal adult thymus (Yui et al., 
2010). 
Global Gene expression Analysis: Selective Changes during Early T-cell 
Development 
To identify when major changes in gene expression occurred along the pathway 
from early T-cell precursor to DP stages, RNA-seq was performed on 2~3 independent 
biological replicates each of FLDN1, FLDN2a, FLDN2b, ThyDN3, and ThyDP cells. At 
least 107 mappable 32 bp reads were obtained for each sample, and independent 
biological replicates were well correlated (r > 0.97) (Figure S1D). Using the programs 
ERANGE and DEGseq to compare expression in different stages, ~10,000 of the 20,861 
Refseq annotated genes were detectably expressed (RNA-seq > 1 RPKM) in each 
population; of these, ~50% statistically significantly changed in expression (p < 0.001) 
between at least one pair of stages and ~ 40% changed overall from FLDN1 to ThyDP 
(Figure 1A).  
Figure 1B shows the hierarchical clustering of the expression patterns of the 3,697 
genes that change expression at least twofold between any stages. Genes undergoing 
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induction between DN1 and DN2b included key T-cell specific genes involved in pre-
TCR expression and function, i.e., genes encoding TCR complex components Cd3g, 
Cd3d, Cd3e, Cd3z (Cd247), T-cell specific signaling components Itk and Lat, 
recombinase Rag1, mutagenic DNA polymerase Dntt, and the surrogate a chain (pTα) 
Ptcra. Transcripts from all of these increased strongly from a low or undetectable 
background level in the FLDN1 stage (Table S2). In addition, a conspicuous group of 
genes were repressed or silenced during these transitions. They included the progenitor-
cell specific growth factor receptor genes Kit, Flt3, and Csf2rb, and also a notable cluster 
of transcription factor genes described below. 
The DN1 to DN2 transition is the first definitive sign of T-lineage entry in 
response to Notch signaling. However, a much larger difference was seen between pre-
commitment FLDN2a and post-commitment FLDN2b cells (2,429 genes different, Figure 
1A, B) than between FLDN1 and FLDN2a (<900 genes different), as supported by 
hierarchical clustering. Conversely, despite their different origins and manipulation, the 
newly-committed FLDN2b and ThyDN3 populations were more similar to each other as 
well (Figure 1A, B). Thus, the major genome-wide transcriptomic changes leading to T-
lineage identity do not occur in the DN1 to DN2a transition. Instead, the cells make a 
larger break via transition into the DN2b or DN3 stages, associated with commitment. 
Transcription Factor Expression Dynamics in T-lineage Commitment 
Genes likely to encode transcriptional regulators (Table 3A, see Supplemental 
Methods) accounted for 379 of the genes that changed expression  ≥2x between stages 
(Table S3B). Hierarchical clustering of their patterns of expression (Figure 1C) 
confirmed the FLDN1 pattern to resemble the FLDN2a pattern, while the FLDN2b 
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resembled the ThyDN3 expression pattern, much more than the pre-commitment 
FLDN2a cells resembled the newly committed FLDN2b. Another major discontinuity 
occurred between the DN2b or DN3 cells and the ThyDP cells (Figure 1C). Thus, the 
major transitions in regulatory gene expression occur at commitment and during the 
TCR-dependent selection event (“ β-selection”) that separates DN3 cells from DP cells. 
From FLDN1 to FDN2b, the most strongly upregulated “regulatory” loci in the 
whole genome were found to be Lef1 and Bcl11b (>75x increased). Pou6f1, SpiB, Ikzf3, 
and Ets1 among others also increased >8x, with weaker increases for known T-cell 
regulators Id3, Tcf12, Gfi1, Tcf7, Hes1, Gata3 (Table S3B). However, many regulatory 
genes sharply decreased in expression between FLDN1 and FLDN2b, including genes 
with known, important functions in hematopoietic progenitors, e.g., Gfi1b, Lmo2, Mef2c, 
Hoxa9, Sfpi1 (PU.1), Gata2, Mycn (NMyc), Cebpb, Bcl11a, Hhex, Nfe2, Lyl1, and several 
Irf factors. A major regulatory shift, with broad repression of progenitor-cell transcription 
factor genes, thus accompanies T-lineage commitment. 
Dynamic Histone Modification Changes Identify Developmentally Regulated 
Promoters and Distal Cis-elements 
The specific cis-regulatory elements affected by changing transcription factor 
action during commitment should be sites of developmentally changing histone 
modifications (Natoli, 2010; Kouzarides, 2007). These are of greatest interest where 
implicated in changes in expression of linked genes (Koche et al., 2011; Weishaupt et al., 
2010; Hawkins et al., 2010; He et al., 2010; Araki et al., 2009). To detect sites of positive 
and negative regulation with high sequence resolution we used ChIP-seq (Johnson et al., 
2007) to enrich DNA associated with three H3 modifications: H3K(9,14)Ac, H3K4me2, 
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and H3K27me3. Histone H3K(9, 14) acetylation (H3Ac) is functionally linked to 
activation at transcriptional start sites (TSS), H3K27me3 is used in one mechanism for 
transcriptional silencing, and H3K4me2 is associated with activation, poising for 
activation or repression, or repression (Wang et al., 2008; Orford et al., 2008; Barski et 
al., 2007; Johnson et al., 2007; Heintzman et al., 2007). For many enhancers, H3K4me2 
provides more precise localization than H3K4me1 (Koche et al., 2011). These marks 
were monitored in two independent biological replicates of each cell type except 
FLDN2a (one sample), with excellent correlation between replicates (Figure S1E).  
The relationships among these marks and RNA expression generally agreed with 
previous studies. Nearly 42,000 “regions” (≥200 bp, Figure S2A) were enriched for 
marks in at least one stage (see Supplemental Methods), of which ~35% were within 1 kb 
of a TSS (“proximal”) and the others in intergenic regions or within transcription units 
(“distal”). The marks were distributed at annotated TSS and non-TSS sites of expressed 
and silent genes as shown in Figure 2A and Figure S2B. Tables S2A (TSS) and S2B 
(non-TSS) summarize modifications at all marked genomic elements at each stage as 
correlated with RNA expression of the nearest genes. Figure S3 presents these 
comprehensive results for TSS and non-TSS sites at all Refseq loci in hierarchically 
clustered heat maps. 
At any given stage, the ~10,000 genes that were detectably expressed were 
overwhelmingly distinguished by H3Ac (85 ± 2%) and H3K4me2 (>91%) at their 
annotated promoters. Silent genes fell into two classes, ~35% with H3K27me3 at their 
promoters and many with unmarked promoters. However, >25% of the silent genes, 
including many with H3K27me3, were still marked with H3K4me2 (Figures S2C, S3), 
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suggesting at least three kinds of repressed states (Filion et al., 2010). Interestingly, silent 
genes encoding regulatory factors were more likely than silent genes overall to be marked 
with H3K27me3 (Figure 2A, B right panels).  
The cumulative probability plots in Figure 2C show that of all genes, those with 
H3K4me2 but not H3Ac at their promoters in a given stage (red tracks), with or without 
H3K27me3, were most likely to be newly repressed or poised for incipient transcriptional 
activation in the next stage. Thus, H3K4me2 alone or bivalent with H3K27me3 marked 
the most developmentally labile promoters in these cells as described elsewhere (Koche 
et al., 2011; Orford et al., 2008). Histone modification at TSS sites was relatively stable 
across development, more than levels of corresponding RNAs (Figure S3A). However, 
distal elements were more dynamically marked: >1/3 of all regions marked with 
H3K4me2 or H3K27me3 in one stage lacked those marks in at least one other stage 
(Figure S3B). Thus the regulatory shifts occurring in development most sensitively affect 
histone marking at non-promoter elements (Heinz et al., 2010; Lin et al., 2010). 
H3K4me2-marked distal elements in fact included a number of previously noted 
regulatory elements (Figure S4A, B): the DP-specific Rag1/2 gene antisilencer 71-75 kb 
5’ of the Rag2 gene (Yannoutsos et al., 2004), and the DN2b/3-specific E1a promoter for 
the Notch1 gene (Gomezdel Arco et al., 2010). Both of these discrete cis-elements 
acquired H3K4me2 specifically at stages when they contribute to gene regulation (Figure 
S4A, B). Other non-TSS regions with developmentally dynamic marking may thus locate 
stage-specific cis-regulatory elements as well. 
Timing of TSS Epigenetic Changes Relative to Transcriptional Changes 
To relate the timing of changes in TSS marks with changes in RNA expression 
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during T-cell commitment, we focused on 3,697 differentially regulated genes. First, 
these were subdivided by K-means clustering into 25 clusters based on expression pattern 
(Figure S5; genes listed in Table S4A). Figure 2D tracks the histone marks from stage to 
stage at the TSS’s of genes undergoing upregulation (clusters 1, 2, and 6), 
downregulation (clusters 7, 9 and 23), and transient decreases (cluster 12) or increases in 
expression (clusters 17 and 19). H3Ac (Figure 2D, first group of columns) was tightly 
coordinated with transcriptional activity (last columns), but H3K4me2 was often present 
before and after expression (second columns, e.g., clusters 1 & 6). Though H3K27me3 
was inversely correlated with expression, only a fraction of the repressed genes ever 
acquired this mark (Figure 2D, third columns). These patterns were confirmed at 
promoters genome-wide (Figure S3A).  
Most relevant to the regulatory decisions that underlie T-lineage commitment 
(Rothenberg, 2011; Yang et al., 2010) are the effects on genes involved in diverse 
hematopoietic cell fates, options that are foreclosed in an ordered sequence during T-cell 
commitment. We identified 389 key hematopoietic genes by Gene Ontology (Table S4B), 
including “signature” regulators of erythroid cells (Gata1, Nfe2, Epor), myeloid cells 
(Sfpi1, Cebpa, Cebpe, Csf1r), B cells (Pax5, Ebf1), NK cells (Eomes, Il2rb), and stem 
cells (Gata2, Tal1, Lmo2). The expression levels of these genes were tracked in T-cell 
precursors (“DN1”-“DP”), in parallel with the changing status of the three histone marks 
at their promoters (Figure 3). Full results are reported in Table S4B and shown in the 
Figure 3 master panel, while labeled subgroups of distinctive expression types are also 
shown in the zoom-in panels so that individual genes can be identified. Again, H3Ac 
modification at promoters was tightly correlated with transcription, while H3K4me2 
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marking also preceded and persisted after transcription.  
The central importance of alternative-lineage exclusion in T-cell commitment 
raised the question of whether common or diverse mechanisms of silencing of non-T 
regulatory genes were used. H3K27me3 use at these functionally relevant loci was both 
variable and dynamic. Some genes were kept silent throughout T-cell specification, and 
many had strong H3K27me3 marks at the promoter, some apparently together with 
H3K4me2 (e.g., Group e, Epor, Irf4, Ebf1, and Eomes) and others without (e.g., Group e, 
Pax5). Other genes were turned off during development, and while these lost H3Ac they 
often gained H3K27me3 (Group d). Some genes poised for early repression already had 
some H3K27me3 at the TSS from FLDN1 stage (e.g., Cebpa in Group e, Gata2, Lmo1, 
Tal1 in Group d), suggesting repression already underway in at least part of the 
population. Yet H3K27me3 did not mandate future silencing, for some T-cell genes like 
Lef1 were strongly activated during commitment despite initially strong H3K27me3 
marking (Figure 3, Group b). Furthermore, other genes stayed silent from FLDN1 to 
ThyDP without any H3K27me3 at the TSS (e.g., Cebpe, Cx3cr1, Zbtb32, Cd79a, and 
VpreB1; Group c). Unexpectedly, these variations in H3K27me3 marking cut across 
myeloid, erythroid, NK cell, and B-cell program boundaries. 
Most Epigenetic Change of Loci Affected by T-cell Development Occurs between 
DN1 and DP 
Both the foreshadowing of future expression by H3K4me2 marking of promoters 
and the ability of some genes to be repressed without appearance of H3K27me3 (Figures 
2D, 3) raised the question of whether critical changes in promoter status occurred during 
the developmental transitions to DN1, or after DP stage. We therefore compared our 
	  	  
64	  
results with H3Ac, H3K4me2, and H3K27me3 ChIP-seq data for a prethymic lymphoid 
precursor population, “PPB” (EBF-/- pre-pro B cells (Lin et al., 2010; Heinz et al., 2010)) 
and with H3K27me3 data for post-thymic naïve CD4 T cells, “CD4” (Wei et al., 2009), 
shown in flanking columns in Figures 2D and 3. This comparison showed that the 
prethymic lymphoid precursor data in general concurred well with the FLDN1 patterns 
for all three histone marks. Furthermore, repressed genes that lacked H3K27me3 marks 
by the DP stage in our samples also remained silent without H3K27me3 marks in the 
peripheral T cells (the uniquely regulated Rag genes were an exception). The FLDN1 to 
ThyDP interval thus encompasses the crucial epigenetic changes for the great majority of 
genes affected by T-cell specification. 
Distinct Mechanisms for Control of Key Developmental Genes 
Changes in modification at distal sites (compiled in Table S2B) as well as TSS 
sites (Table S2A) often appeared implicated in gene regulation, as shown for the key 
genes highlighted in Figure 4.  
Figure 4A, B illustrate two highly T-cell-specific loci activated in parallel from 
DN2a to DN2b, the Cd3gde gene cluster and Bcl11b, respectively. These genes initially 
lack RNA transcripts (Figure 4, black tracks) and H3Ac marks (blue tracks) in the 
FLDN1 cells, but then are strongly upregulated and kept on thereafter. For the Cd3 genes, 
there was no H3K4me2 (red tracks) at the promoters and light H3K27me3 marking 
across the locus (Figure 4A, green tracks) during the initial silence, but the classic 
enhancer elements at the 3’ ends of Cd3e and Cd3d (Georgopoulos et al., 1988; van de 
Wetering et al., 1991) were already marked by focal H3K4me2. Note that these 
enhancers were already accessible to transcription factor binding even in the FLDN1 
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stage, as shown by ChIP-seq evidence for binding by the factor GATA-3 (Figure S4C; 
see below). These H3K4me2 sites then intensified while both H3Ac and H3K4me2 were 
recruited to the promoters of the genes during the DN2a/2b stages, when transcription 
began. A similar pattern for early activation without initial promoter marking was seen 
for Il2ra (Figure S4D).  
In contrast to the Cd3gde cluster, the Bcl11b gene (Figure 4B) began with 
substantial H3K27me3 (green tracks) over its promoter and across the whole gene body 
at FLDN1 stage. However, its TSS also had a cryptic positive cis-regulatory element 
marked by H3K4me2. Bcl11b then was activated from FLDN2a to FLDN2b stage 
through a process that swept back the H3K27me3 repressive marks off the promoter, 
while expanding the H3K4me2 marks into the first intron and creating a new H3K4me2 
marked region in the third intron.  
The changes in histone marks at these loci contrast sharply with the precisely 
positioned but virtually unchanging H3K27me3, H3Ac, and H3K4me2 marks that 
characterized the Gata3 gene (Figure 4C). Despite a block of H3K27me3 close to the 
major promoter, this gene was already activated by the time of the FLDN1 stage and 
underwent only a few-fold increase in expression after that.  
Repression of essential B-cell regulatory factors, myeloid-cell regulatory factors, 
and stem or progenitor-cell regulatory factors is a crucial aspect of T-lineage 
commitment. This clearly required a variety of distinct mechanisms (Figure 4D-H). The 
Pax5 gene, crucial for the B-cell program, had no H3Ac modified regions at any stages 
(Figure 4D; compared with neighboring Zcchc7 promoter mark). Four small peaks of 
H3K4me2 modification were seen in intronic regions, one of them corresponding to a 
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known hematopoietic enhancer (Decker et al., 2009). However, the gene was completely 
buried in H3K27me3 at all stages. Ebf1 (Figure S4E) was also repressed from FLDN1 on 
despite H3K4me2 at several sites.  
Hhex and Bcl11a (Figure 4E, F), in contrast, were expressed strongly in FLDN1 
cells but then downregulated sharply by the FLDN2b/ThyDN3 stages, showing evidence 
of distinct modulating roles for distal and TSS elements. For Hhex (Figure 4E), the TSS 
and two H3K4me2-marked distal regions lost activation marks as expression decreased, 
while H3K27me3 appeared focally at the TSS and then spread. A similar pattern was 
seen for Flt3 and the Zbtb7b (Thpok) gene, which were active in FLDN1 and then 
repressed (Figure S4F, I). For Bcl11a (Figure 4F), H3Ac persisted at the promoter while 
RNA expression declined during commitment, reflecting a tail of low-level expression 
through DN3. Here, H3K27me3 marks only appeared at the last stage of silencing at the 
DP stage. However, the H3K4me2 modification of an element just downstream of the last 
exon decreased sharply between FLDN2a and FLDN2b, in parallel with RNA expression, 
suggesting a potential regulatory role.  
The myeloid and progenitor-cell transcription factor gene Sfpi1 (encoding PU.1), 
silenced in parallel with Hhex and never re-expressed in most T-cell lineages, used a 
different mechanism of repression (Figure 4G). H3Ac disappeared from the promoter 
while H3K4me2 marks in the upstream cis-regulatory elements of the gene 
(Hoogenkamp et al., 2007; Rosenbauer et al., 2006; Zarnegar et al., 2010) became 
narrowed as transcription declined (Figure 4G). Yet minimal H3K27me3 was deposited. 
Not only were H3K27me3 marks dispensable for repression; they were also 
labile. Figure 4H shows that dense H3K27me3 marks on Mpzl2 (same as Eva1) 
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diminished during transient induction of RNA expression in the DN2b and DN3 stages, 
but then returned during re-silencing in DP stage. Conversely, despite potent silencing, 
Zbtb7b (Figure S4I) is later reactivated for CD4+ cell positive selection. 
Early T-cell Specific Sites for PU.1: A Positive Role 
The functional interplay between histone modifications and transcription factors 
could be probed by monitoring the binding patterns of known transcription factors, to 
evaluate site accessibility and the order of transcription factor binding relative to histone 
marking. We focused on two well-studied factors with contrasting roles, GATA-3 and 
PU.1 (encoded by Sfpi1), which are both needed for early T-cell development, playing 
dose-dependent, stage-specific roles in collaboration with Notch signals (Rothenberg and 
Scripture-Adams, 2008; Hosoya et al., 2010). PU.1 is a key representative of the 
progenitor-associated cohort of transcription factors in early pro-T cells. As PU.1 is even 
more critical for B, dendritic and myeloid cell development, an issue is whether it has 
distinct T-lineage target genes or simply delays or interferes with commitment.  
PU.1 bound to about 34,000 sites in double negative T cells, comparable to B and 
myeloid cells (Heinz et al., 2010). Although PU.1 RNA and protein levels decline sharply 
during T lineage commitment (Figure 5A) (Yui et al., 2010), PU.1 site binding 
preferences were highly consistent from stage to stage. We compared FLDN1 and 
FLDN2a cells; FLDN2b cells, where PU.1 is at least 4-5x downregulated; and DP cells, 
where PU.1 is absent. Although PU.1 binding intensity per site was reduced 4-5x in the 
FLDN2b cells, its site choices remained highly correlated with those in the earlier stages 
(r = 0.65-0.66) (Figure 5B). Thus, within T-cell precursors, a major determinant of PU.1 
binding at most sites may simply be PU.1’s own availability.  
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Nevertheless, the PU.1 binding sites in FLDN1 and FLDN2a cells were not the 
same as those reported for PU.1 binding in B cells, macrophages or E2A-/- pre-pro B cells 
(representing prethymic lymphoid progenitors (Heinz et al., 2010)) (Figure 5C). 
Although most closely related to the sites bound in multipotent E2A-/- pre-pro B cells 
overall, some known PU.1 target sites bound by PU.1 in pre-pro B cells were not 
accessible to PU.1 binding in the FLDN1 cells, e.g., the intronic enhancer of Pax5 
(Figure 5D). De novo motif analysis showed that PU.1 target sites in FLDN1 cells also 
included a different hierarchy of preferred sequences than in the pre-pro B cells (Figure 
5E). Thus, the consistent site choices of PU.1 from DN1 stage through commitment 
include a distinct T lineage-specific component.  
PU.1 is required to generate T-cell precursors, but at high levels it inhibits 
expression of many T-cell specific genes, particularly when Notch signaling is 
interrupted (Franco et al., 2006). To test whether the special T-lineage specific roles of 
endogenous PU.1 may be to delay T-cell gene activation, we asked whether the PU.1 
sites specific to early T cells were most often linked to genes that are active or repressed, 
as compared with sites that were only bound by PU.1 in non-T, E2A-/- pre-pro B cells. 
Results showed that sites actually bound by PU.1 in FLDN1 cells, including FLDN1-
specific sites, were broadly associated with “positive” marks (H3Ac and/or H3K4me2) 
and completely uncorrelated with H3K27me3 marking, unlike sites bound by PU.1 only 
in E2A-/- pre-pro B cells (Figure 5F). In the aggregate, genes with sites actually bound by 
PU.1 in FLDN1 cells were also much more likely to show strong expression than those 
with potential PU.1 sites unoccupied, with higher expression the more sites bound 
(Figure 5G). This was true of FLDN1-specific sites as well as of sites occupied in both 
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FLDN1 and pre-pro B cells. Thus, PU.1 binding globally correlates with positive target 
gene regulation in FLDN1 cells. 
PU.1 Binding Dynamics, Histone Marking, and Temporal Control of Target Gene 
Expression 
Experimental perturbation analyses have shown many specific genes in pro-T 
cells that are activated or repressed by manipulations of PU.1 level (Franco et al., 2006) 
(A. Champhekar, M. M. Del Real, and E. V. R., unpublished data). However, with so 
many binding sites for PU.1, binding alone clearly could not define genes that depend on 
PU.1 for positive or negative regulation. Most PU.1 binding sites in fact were linked to 
genes expressed stably in all stages whether PU.1 is present or not, like the majority of 
genes expressed in T-cell development overall. PU.1 may thus be recruited to sites at 
many active genes where it has no required role. The challenge was to filter the binding 
sites identified genome-wide to enrich for functionality, to consider properties of likely 
functional sites in global terms. 
Whereas PU.1 sites linked to stably expressed genes may include many 
opportunistic “passengers”, functionally important PU.1 sites should be enriched near 
genes which themselves change in RNA expression, up or down, during development as 
PU.1 binding to their regulatory sites declines. To assess broadly whether PU.1 
participates in positive or negative regulation at a given set of loci, we compared changes 
in local PU.1 occupancy from FLDN1 to FLDN2b with the direction and magnitude of 
changes in RNA expression of the genes linked to those sites. 
First, we considered a pool of all genes up or downregulated from DN1 to DN2b 
(Figure 6B) and reclassified them purely according to whether their linked sites lost PU.1 
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occupancy faster (Figure 6B-C, blue) or slower (red) than the global ~4x average (green 
= genes with both kinds of sites). We then assessed whether these changes in PU.1 
occupancy predicted the direction of changes in mRNA expression across the same 
interval (Figure 6C), i.e., whether early PU.1 loss was more linked to genes turning off 
like PU.1 itself, or with upregulating genes that PU.1 might initially have repressed. 
These cumulative probability plots could reveal either group-wide trends or subgroups 
with different expression trends within each group. Second, we classified individual PU.1 
sites according to whether their linked genes were upregulated, downregulated, stably 
expressed, or silent across the DN1 to DN2b interval. We then asked whether expression 
categorized sites tended to lose PU.1 faster or slower than sites linked to stably expressed 
genes, a standard for likely full epigenetic accessibility (Figure S6A).  
The results implied that PU.1 binding is rarely if ever directly repressive, whether 
the genes are expressed in the same pattern as PU.1 or not. Figure 6C shows that genes 
which lost PU.1 occupancy most rapidly (blue curve) were more likely downregulated 
(log2(FLDN2b/FLDN1) < -1) and less upregulated than those with mixed sites. 
Conversely, almost 80% of genes with sites that retained PU.1 best (red curve) increased 
their expression from FLDN1 to FLDN2b. In accord, the changes in PU.1 occupancy at 
individual binding sites were significantly different for downregulated, upregulated, and 
stably expressed genes (Figure S6A), such that sites linked to the upregulated genes 
retained PU.1 even better than fully “accessible”, stably expressed ones.  
PU.1 binding can recruit histone methyltransferases and create locally 
“accessible” chromatin states (Ghisletti et al., 2010; Heinz et al., 2010), and in early T-
lineage cells as in non-T cells, PU.1 occupancy was dynamically linked with local 
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H3K4me2 modification. Due to the developmental stability of H3K4me2 modification at 
TSS overall, this was most evident at distal PU.1 binding sites, where H3K4me2 
modification usually melted away as PU.1 binding decreased (Figures S6B, bottom & 
S6D). In contrast to H3K4me2, PU.1 binding had little overlap with H3K27me3, even at 
silent genes (Figure S6C1, 2; S6D). PU.1 binding-linked H3K4me2 was not simply an 
effect of general “accessibility” or expression level of the linked gene (Figure S6D, 
“silent” vs. “E2A-/-” sites). Thus, PU.1 occupancy-linked changes in H3K4me2 could be 
used to screen candidate distal cis-regulatory sites with PU.1-dependent activity.  
At candidate target genes both identified by co-regulation with PU.1 and by PU.1 
activity perturbation effects, PU.1 typically occupied multiple sites, implying that full 
PU.1 regulatory function is commonly mediated through combinations of binding 
complexes. At Tal1, both PU.1 binding and local H3K4me2 were lost jointly from three 
sites, as transcription also declined (Figure 6D). At the TSS regions and intragenic sites, 
PU.1 loss appeared to open the way for H3K27me3 deposition. Similar patterns were 
seen at the TSS regions of the known PU.1 target Flt3, and at a downstream element and 
a known intronic enhancer of Hhex (Donaldson et al., 2005) (Figure S4F, G). Other genes 
with binding sites that lose PU.1 early include Lmo1 and Bcl11a as well as Itgam, which 
decrease naturally from FLDN1 to FLDN2b; all are sharply downregulated in FLDN2 
cells if Sfpi1 is deleted (not shown; A. Champhekar, M. M. Del Real, S. Carotta, S. Nutt, 
and E. V. R., unpublished). Many sites most sensitive to loss of PU.1 may thus mediate 
rate limiting positive regulatory function. At the other extreme, persistent PU.1 binding 
occurred at the Il7r locus, which is upregulated from FLDN1 to FLDN2b. Despite the 
decreasing level of PU.1 protein, PU.1 occupancy at the Il7r gene remained essentially 
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unchanged by FLDN2b stage, both at a known TSS positive regulatory site (DeKoter et 
al., 2002; Xue et al., 2004), and at another putative cis-element within a silent 
neighboring gene, Capsl (Figure 6E). Here too PU.1 occupancy sites have a positive link 
to expression, even for this gene integral for the T-cell program.  
Globally, with or without distal binding sites, PU.1 binding near the TSS 
appeared most consistent with a positive role (Figure 6F). Genes of diverse expression 
pattern clusters (defined in Figures 2D and S5) could all harbor PU.1 binding either 
within the body of the gene or in flanking regions, but differed sharply in frequencies of 
genes with PU.1 binding at the TSS regions (Figure 6G; Table S6). Genes coregulated 
with PU.1 itself (clusters 7; also 3, 9 & 23; blue bars) were more likely to have PU.1 
binding at the TSS regions than genes regulated divergently from it (clusters 1, 2, 6, and 
other clusters; red bars). Progenitor-specific genes with TSS binding included Bcl11a, 
Gfi1b, and Irf5 (Table S6B) as well as Tal1 and Hhex. In contrast, many T-cell genes that 
can be downregulated by high-level PU.1 (Franco et al., 2006) either had no PU.1 
binding in early T cells or had binding only in the body or flanking regions of the genes. 
Genes with particularly low expression in DN1 stage were most impoverished for PU.1 
sites at the TSS regions (Table S6A, χ2 test p < 0.0001). Thus, PU.1 binding at the 
promoter may provide or indicate specific antisilencing functions that maintain key stem- 
and progenitor-cell genes in early FLDN1 and FLDN2a stages. 
Developmentally Plastic Deployment of GATA-3 Binding 
GATA-3 is needed repeatedly in T-cell stages from ETP/DN1 onward and is 
crucial for T-lineage commitment, but capable of paradoxical effects at high doses 
(Taghon et al., 2007). Unlike PU.1, it is expressed almost stably across all the stages 
	  	  
73	  
analyzed (Figure 4C; and unpublished results). We therefore asked whether it acts 
through the same sites in the distinct regulatory states of FLDN1, FLDN2b, and ThyDP 
cells.  
GATA-3 detectably bound only ~1,500 sites (Table S7). In accord with its 
recurrent T-cell roles, these GATA-3 sites were prominently enriched for cis-elements of 
T-lineage genes including Cd3d, Tcf7, Zbtb7b, and the DP-specific Rag1-Rag2 distal 
enhancer (Figure S4C, H, I, B). Yet progenitor-specific genes like Lyl1 and Erg (Figure 
7A, B) as well as later-expressed T-cell genes like Ets2 and Itk (Figure 7C, D) harbored 
GATA-3 sites. Occupancy patterns in our ThyDP samples were broadly consistent with 
those in DP CD3lo samples published elsewhere (Wei et al., 2011) (r = 0.60; Figure S7A).  
Changes in GATA-3 binding were positively correlated with expression 
trajectories of linked genes both from DN1 to DN2b and from DN2b to DP (Figure 7E), 
and these were also correlated with H3K4me2 modification changes (Figure 7F). GATA-
3 binding was even more likely to be a site of H3K4me2 enrichment than PU.1 binding 
(Figure S7B). Yet GATA-3 also bound sites linked to silent and active genes alike at 
early stages, and dramatically differed from PU.1 in its ability to engage sites with 
H3K27me3 marks (Figure S7C). For example, it remained bound to Zbtb7b even as it 
became silenced with H3K27me3 (Figure S4I). Intriguingly, GATA-3 occupancy also 
preceded full cis-element activation for Cd3d and the Rag enhancer (Figure S4B, C), 
suggesting a possible “pioneering” role.  
However, the distribution of GATA-3 occupancies among different sites was 
strikingly different in FLDN1, FLDN2b, and ThyDP. This was despite nearly constant 
protein availability: global occupancy levels and peak heights at stably occupied sites 
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such as the Tcf3 (Tcfe2a) promoter (Figure 7D) and the Tcrb 3’ enhancer (not shown) 
were similar in all stages. Also, the most common motifs at sites of occupancy were a 
classic GATA site and an Ets family-like site (Figure 7G), in FLDN1, FLDN2b, and 
ThyDP alike. But from FLDN1 to ThyDP, GATA-3 occupancy increased sharply at some 
sites (e.g., Ets2 in DN2b, Itk promoter in DP; Figure 7B, C), while disappearing from 
others entirely (e.g., Lyl1, Erg, Itk introns; Figure 7A-C). Overall, whereas sites occupied 
in FLDN1 and FLDN2b stages were moderately well correlated (r = 0.61), sites in 
FLDN2b and ThyDP were poorly correlated (r = 0.22) and those in FLDN1 and ThyDP 
entirely uncorrelated (r = -0.0064, Figure 7H). 
These results locate elements in T and non-T genes where the crucial T-cell factor 
GATA-3 can be contributing to regulation, from the FLDN1 stage on (Table S7). 
Nevertheless, they also reveal that a target gene for GATA-3 at one stage of T-cell 
development may not normally receive input from GATA-3 at another stage, despite 
similar GATA-3 availability. In contrast to PU.1, GATA-3’s physiological deployment at 
any given stage depends not only on its own availability but also on a specific 
developmental regulatory context. 
 
DISCUSSION 
Our results provide a resource for T cell development, a new reference case for 
regulatory epigenomics, and potentially powerful new explanatory elements for a 
complex developmental process.  
For T-cell development, the results here provide a global, base-resolution time-
course of the chromatin landscape and transcriptome during the finely defined stages of 
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T-cell specification, which substantially extends previous knowledge. The transcriptome 
data not only quantify RNA levels but also provide detailed information about promoter 
and exon choice that may affect gene regulation as well as function. We also note that 
these data reveal noncoding transcripts that maybe important in various regulatory roles. 
Here, we focused on two elements of greatest causal importance to explain T-cell 
identity: the ~400 regulatory gene loci that themselves are developmentally regulated 
during this process, and also the particular subset of candidate cis-regulatory genomic 
sites that undergo developmental changes in histone modifications in response to changes 
in local regulatory inputs. These are the most likely trans and cis-components of nodes in 
the gene network that gate successive steps of the T-cell program. For example, the 
mapping of specific GATA-3 binding sites at a core set of important T-cell genes will 
clearly speed resolution of the role of this crucial factor during early T-cell specification. 
Most powerfully, the results reveal the subcomponent processes out of which T-
cell specification is built. Our results confirm that relatively few regulatory genes 
undergo strong upregulation during lineage commitment itself. Instead, a major feature 
integrally linked to commitment is specific and marked downregulation of progenitor-cell 
genes, which is revealed to be unexpectedly complex. Important non-T hematopoietic 
regulatory genes are still expressed in the precursors through 4 days of consistent Notch 
pathway signaling, and many persist even into the DN2a stage before they are shut off. 
However, their repression during commitment is not due to a single switching 
mechanism, nor is due to the decay kinetics of old mRNA retained long after 
transcription has ceased. Importantly, the histone marking status of the promoters and 
linked cis-elements provides an independent line of evidence about the timing of 
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regulatory changes, supplementing measurements of population mRNA levels. Thus, the 
diverse histone mark transformations that are applied to different repression targets imply 
that a variety of biochemically and temporally distinct silencing mechanisms must be 
used. Notably, this rules out Notch signaling itself as a common mechanism of repression 
and implies that the T-lineage program deploys multiple waves of repressor functions 
needed to establish T-cell identity.  
Dynamically regulated transcriptional repression during this process is often 
separable from “epigenetic silencing”. At finest scale, our results show that deposition of 
H3K27me3 histone marks is more probably an effect and stabilizer of repression than an 
initial cause of repression. De novo H3K27me3 marking accumulates at newly-repressed 
loci in two distinct, major patterns. One appears to be lateral invasion from a neighboring 
patch of pre-existing “closed” chromatin, often after a positive regulator (e.g., PU.1) is 
removed, but this can be forestalled indefinitely as in the case of the Gata3 locus. 
Another is by tight focal deposition at a previously active TSS or enhancer site, followed 
by spreading. At many downregulated genes in our survey, decreased RNA levels clearly 
precede deposition of H3K27me3. In other cases repression does not involve H3K27me3 
at all, including Sfpi1 and Cd4, two key genes known to be repressed by Runx factors in 
DN3 cells. Even when H3K27me3 is used, it is readily and precisely reversible. 
Repression via DNA methylation was not studied here but is also reversible, as shown 
recently by the cell type-specific demethylation of CpGs in DN2-DN3 cells at loci that 
include Tcf7 and Bcl11b (Ji et al., 2010) (http://charm.jhmi.edu/hsc/). These examples 
underline the need for transcriptional repressors to act first to trigger chromatin closing, 
and the power of transcriptional activators to undo it. 
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Our results also address a long-standing question in T-cell development, namely 
explaining how the positive drivers of the T-cell program work. Essential roles for 
GATA-3, Notch1 and TCF-1 were established early, but validation of their specific cis-
regulatory targets has been slow. GATA-3 effects in early T cells have been especially 
difficult to dissect, in part due to the profound loss of viability when GATA-3 dose is 
reduced (Hosoya et al., 2009), and in part due to lineage-inappropriate effects of GATA-3 
in gain of function experiments (Taghon et al., 2007). The identification of a battery of 
cis-regulatory elements activated de novo from DN1 to DN2b is an important new 
resource for clarifying these links. Identification of sites for potential GATA-3 regulatory 
inputs into Tcf7 as well as Tcfe2a suggests a new level of regulatory interlinkage, which 
could explain the acuteness of the GATA-3 requirement. At least in DP cells, data from 
(Wei et al., 2011) do suggest that the GATA-3 binding we see positively regulates Tcf7, 
Cd3d, and possibly Zfpm1, and negatively regulates Tcfe2a. Our results may also help to 
explain GATA-3’s lineage infidelity in gain of function experiments by revealing how 
conditionally this factor normally provides its inputs at legitimate target sites. Even at a 
fixed level of expression, GATA-3’s action is stage specific. Altered dosages could thus 
override the mechanisms that must provide appropriate targeting specificity.  
T-lineage commitment is an ordered process in which different alternative 
hematopoietic fates are relinquished sequentially. We show that the repressive events 
through which alternative lineages are excluded are mechanistically separable. Thus the 
B-cell regulatory genes Pax5 and Ebf1 are silenced by H3K27me3 and rendered 
inaccessible to PU.1 binding from the start, whereas the myeloid regulatory gene Cebpa 
is bivalently marked. The myeloid and progenitor regulatory gene Sfpi1 (PU.1), initially 
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fully activated, plays a surprisingly effective regulatory role even into the DN2b stage, 
and is silenced only when T-cell gene expression is under way. However, there is no 
simple mapping of developmental lineage exclusion order with a particular molecular 
class of repression mechanism. Drivers of the most “distant” fate in developmental terms, 
the erythroid genes, can be repressed via H3K27me3 (EpoR), or without it (Gata1), as 
can genes associated with the “closest”, NK-cell fate (Eomes, Il2rb respectively). Like 
Sfpi1, multipotent progenitor-cell regulatory genes are strongly expressed initially and 
shut off during the commitment process. Many of these genes may be sustained by a 
common progenitor-cell positive regulator, Lmo2 (McCormack et al., 2010), and we 
show many are also direct binding targets of PU.1 itself. Each of these genes responds to 
its own combination of positive and regulatory inputs, as a distinct node in the T-lineage 
specification network. Indeed, the complexity and diversity of mechanisms revealed in 
this initial global study argue that evolution has drawn liberally on combinations of 
factors and pathways to regulate a T-cell developmental progression that integrates 
multiple external and internal inputs.  
Our multistage analysis shows that many mouse hematopoietic genes are each 
likely controlled by different constellations of cis-regulatory elements at one stage of 
development versus another, even within the same cell lineage. In this light, the quest for 
single, minimal sufficient regulator elements for such genes seems naïve, as it would a 
priori sacrifice the full range of developmental control. The roles of the candidate cis-
elements and their rules for engagement with promoters should be greatly clarified by 
future extensions of this analysis, to detect specific chromatin looping events, enhancer 
activation states mapped by association with p300 and H3K4me3, and latent enhancers 
	  	  
79	  
using H3K4me1 at transcription factor binding sites. Mechanisms of repression could be 
clarified when effects on a broader range of non-activating cis-elements are mapped 
based on DNase hypersensitivity and DNA methylation. The mapping of 
developmentally dynamic histone modification sites provides a new way to locate the 
sites in cis-regulatory DNA that process distinct inputs for crucial regulatory genes. In 
this collection of regulatory domains lie the answers to how cells are driven to T-lineage 
commitment. 
 
METHODS 
Full materials and experimental procedures are given in the Supplement. 
Accession codes. GEO:GSE31235. 
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Figure 1. Global comparisons of gene expression among five developmentally 
related immature T cell populations. 
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A. Pair-wise comparisons in gene expression between successive populations as well as 
initial FLDN1 vs. final ThyDP stages. Statistically changed genes were defined by 
DEGseq (p < 0.001).  
B. Hierarchical clustering of expression patterns of all differentially expressed genes. 
Expression levels of all DEGseq positive genes with ≥2x difference in expression are 
hierarchically clustered along both sample and gene dimensions and displayed as a 
heatmap. 
C. Hierarchical clustering of expression patterns of differentially expressed transcription 
factors. Several known early T cell development related transcription factors are 
indicated. 	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Figure 2. Distinct gene expression patterns are associated with characteristic histone 
modifications. 
A. Association of gene expression and histone modifications at the promoters of 20,861 
UCSC annotated genes. Expressed (≥1 RPKM) and silent (<1 RPKM) genes in each 
stage were distinguished by RNA-seq. Color shading denotes the level of the given 
histone modification at promoters, defined as ±1 kb of the TSS. Ac: H3Ac, me2: 
H3K4me2, me3: H3K27me3. 
B. Association of gene expression and histone modifications at the promoters of 1,646 
genes encoding DNA-binding proteins or transcription factors.  
C. Association of promoter-linked histone modifications with developmental change in 
expression. Genes are grouped based on histone marks of their TSS in the FLDN2a (top) 
or ThyDN3 (bottom) stages: H3Ac- H3K4me2+ (H3K27me3+ or -) in red, H3Ac+ 
H3K4me2+ H3K27me3- in blue, H3Ac- H3K4me2- H3K27me3+ in green, and H3Ac- 
H3K4me2- H3K27me3- in black. Plots show the cumulative distributions of genes in 
each group with various degrees of expression change from the previous stage to the 
following stage, i.e., from FLDN1 to FLDN2b (top), and from FLDN2b to ThyDP 
(bottom). Genes showing different changes in expression (log2 ratio of RNA-seq levels) 
are separated on the x-axis, with downregulated genes to the left and upregulated genes to 
the right, and their fractional representations within the group are accumulated on the y-
axis. The group of genes that were H3Ac-/H3K4me2+, with or without H3K27me3, are 
most developmentally labile, with >20% that are downregulated more than 2x and >20% 
that are upregulated more than 2x (vertical lines: boundaries for >2x change), and this 
difference is highly significant (Kolmogorov-Smirnov [K-S] (two-sided) test for 
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comparison between H3Ac-/H3K4me2+ and each of the other three groups; p value for 
each comparison in parentheses). 
D. Heatmaps correlating TSS histone modifications with various patterns of 
developmentally regulated gene expression for 9 representative clusters (see Figure S5). 
Clusters 1, 2, and 6: upregulated from DN1 to DP stage. Clusters 12, 17 and 19: genes 
transiently changed in mRNA expression from DN2a to DN3. Clusters 7, 9, and 23 
downregulated from DN1 to DN2b stage. Normalized signal densities of histone 
modifications at the promoter region of each gene were aligned with normalized mRNA 
data, and hierarchical clustering (one-dimensional, along genes) was performed for 
individual clusters using Ward linkage and Euclidean distance. As comparisons, histone 
modification data from EBF-/- pre-pro B cells (H3Ac, H3K4me2 and H3K27me3; “PPB”) 
and CD4 naïve T cells (H3K27me3 only, “CD4”) were then added to the heatmaps after 
the hierarchical clustering had been generated.  
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Figure 3. Histone modifications and gene expression profiles of genes characterizing 
hematopoiesis.	  
Results for 379 “hematopoietic” genes are processed and displayed as in Figure 2D. 
Master panel shows results for all 379 genes. Signature cluster regions (a-e) are zoomed 
in to allow individual genes to be seen. 
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Figure 4. Portraits of key T-lineage and alternative-lineage genes. 
A – H. UCSC browser track images depicting distinct epigenetic marking and gene 
expression patterns at eight different loci: Bcl11b (A), Cd3e/d/g cluster (B), Gata3 (C), 
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Pax5 (D), Hhex (E), Bcl11a (F), Sfpi1 (G) and Mpzl2 (H), in all five immature T-
populations (top to bottom, DN1, DN2a, DN2b, DN3 and DP). Red arrow: TSS and 
direction of transcription. H3Ac: blue, H3K4me2: red, H3K27me3: green, and RNA-seq: 
black. Uniform scales are used for histone marks in all panels, and mRNA scales are 
uniform within each panel, as shown by y-axis labels (units in RPM for ChIP-seq, RPKM 
for RNA-seq). Chromosomal coordinates are indicated below each panel. 
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Figure 5. Lineage specific PU.1 DNA binding is associated with lineage specific 
histone modifications and gene expression. 
A. Mean RNA-seq level of PU.1 (Sfpi1) at each stage of early T cell development. 
B. (Left) Comparisons of PU.1 DNA binding site distributions between FLDN1 and 
FLDN2a or FLDN2b. Pearson’s correlation coefficient for each comparison (r) is 
indicated. (Right) Comparisons of PU.1 DNA binding-associated H3K4me2 enrichment 
between FLDN1 and FLDN2a or FLDN2b. H3K4me2 signal densities were calculated 
within ±1 kb of the summit of a given PU.1 bound region (as in Figure 5B).  
C. Comparisons of PU.1 DNA binding between FLDN1 and E2A-/- pre-pro B, 
macrophage or mature B cells.  
D. Lineage-specific PU.1 binding at the Pax5 locus. B cell specific Pax5 intronic 
enhancer is bound by PU.1 (black arrow) in E2A-/- pre-pro pre-pro B cells (Heinz et al., 
2010) (black track), but not in DN cells (brown tracks). PU.1 ChIP-seq in ThyDP is used 
as a negative control. For orientation, H3K4me2 pattern in DN1 stage is included (red 
track). Note low level of H3K4me2 modification at the non-T specific PU.1 binding site, 
within a known Pax5 enhancer (Decker et al., 2009). 
E. Lineage specific and shared PU.1 binding sites between FLDN1 and E2A-/- pre-pro B 
cells. Lineage specific binding regions: more than 4x difference in PU.1 occupancy 
between the two populations. Sequence logos are shown for the most highly enriched 
sequence motif for each occupancy subgroup. Percentages of regions from the three 
subgroups containing at least one instance of each motif are indicated in parentheses 
beneath each sequence logo (E2A-/- specific/Shared/FLDN1 specific). 
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F. Distribution of the enrichment of specified histone modification over genomic regions 
within ±1 kb of lineage specific and shared PU.1 binding sites in FLDN1 cells.  
G. Correlation of mRNA expression levels in FLDN1 with presence of lineage-specific 
or shared PU.1 sites. Distribution of mRNA value in FLDN1 for subgroups of genes that 
are linked to either E2A-/- pre-pro B specific, FLDN1 specific, or shared PU.1 binding 
sites, and genes linked to more than one PU.1 site occupied in FLDN1 cells (Multiple). 
K-S test for mRNA levels was performed between E2A-/- Specific Only and each of the 
other three subgroups (number of genes in each group and p values in parentheses). 
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Figure 6. Functional and stage-dependent PU.1 binding in early T cell development. 
A. Stage specific and non-stage-specific (shared) PU.1 binding sites: stage specific 
binding defined by ≥4x difference in signal densities between FLDN1 and FLDN2b. 
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B. Differential expression of PU.1 binding linked genes. Among 13,335 PU.1 binding 
linked genes in DN cells, 1,045 genes were differentially expressed (≥2x change in 
expression), with 502 genes downregulated and 543 upregulated from FLDN1 to 
FLDN2b. The rest of genes include 7,244 stably expressed genes (<2x change in 
expression) and 5,046 silent genes (<1 RPKM in both stages). Based on the type(s) of 
associated PU.1 binding sites (as in 6A), differentially expressed genes were divided into 
three subgroups: genes linked only to FLDN1 specific sites (Loss of PU.1 binding in 
FLDN2b, blue), those with either shared or FLDN2b specific sites or both (Retaining of 
PU.1 binding in FLDN2b, red), and genes that rapidly lose PU.1 binding in some sites 
while retain binding in other sites (Mixed, green). 
C. Relationship between PU.1 occupancy patterns and changes in mRNA expression 
between FLDN2b and FLDN1. Plots are cumulative distributions of expression changes 
for three groups of genes depicted in B. The number of genes in each group and p values 
(K-S tests for comparisons with “Mixed”) are indicated next to the plots. 
D & E. Developmentally distinct PU.1 binding patterns at the Tal1 (D) and Il7ra (E) loci 
in FLDN1, FLDN2a, FLDN2b and E2A-/- pre-pro B cells, compared with H3K4me2, 
H3K27me3 and mRNA in all five immature T-populations. Note several PU.1 bound 
sites with an occupancy pattern similar to Il7r sites in the silent Capsl downstream. 
F. Distribution of PU.1 sites in individual stages. In each stage, PU.1 binding sites were 
divided into four subgroups based on the location (promoter-proximal and -distal) and 
expression level of binding sites associated genes (expressed and silent).  
G. Location of PU.1 sites in potential target genes according to expression pattern. Genes 
with PU.1 binding sites from clusters with different developmental expression patterns 
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(Figure S5) were classified according to the location of PU.1 binding, within 1 kb of the 
TSS (proximal) or in non-TSS sites (distal). Point symbols (left axis) show the 
percentages of genes in a cluster with PU.1 binding to each region type. Bar graphs show 
the ratio of the number of genes in a cluster with TSS sites to the number of genes in the 
cluster with distal sites, to correct for accessibility (right axis). Colors of bars denote 
similarity of expression pattern of each cluster to endogenous PU.1 expression (most 
similar: blue; inverse: red). See Figures 2D, S5, &Table S6. 
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Figure 7. Developmental plasticity of GATA-3 DNA binding and associated 
epigenetic marking.  
A – D. Stage-specific GATA-3 binding (brown) in Lyl1, Ets2-Erg, Itk and Tcfe2a loci of 
FLDN1, FLDN2b and ThyDP cells, shown with binding associated H3K4me2 (red) and 
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H3K27me3 (green) enrichment and mRNA (black) expression in all five immature T-
populations.  
E. Cumulative distributions of changes in GATA-3 occupancy between FLDN2b and 
FLDN1 (top) and between ThyDP and FLDN2b (bottom), for genes differentially 
regulated across the same intervals. GATA-3 binding sites (see panel H) were divided 
into four subgroups, based on linkage to downregulated genes (blue), upregulated genes 
(red), stably expressed genes (<2x change in expression, green) and silent gene sites (<1 
RPKM in both stages, black). P values from K-S tests between stably expressed gene 
sites and each of the other three subgroups and the number of sites in each group are 
shown. 
F. Cumulative distributions of changes in H3K4me2 marks associated with GATA-3 
binding between FLDN2b and FLDN1 (top) and between ThyDP and FLDN2b (bottom) 
stages. H3K4me2 signal densities were calculated within ±1 kb of the summit of a given 
GATA-3 bound region (depicted in Figure 7H). K-S test was performed between stably 
expressed gene sites and each of the other three subgroups as described in 7E. The 
number of sites in each group and p value for each comparison are indicated in 
parentheses. 
G. Most highly enriched sequence motifs in GATA-3 binding regions (see panel H). The 
percentages of regions containing at least one instance of each motif are indicated 
beneath each sequence logo, with the expected frequency of the motif in random regions 
in parentheses.  
H. Scatter plots depicting the comparisons in GATA-3 binding between FLDN1, 
FLDN2b and ThyDP. Pearson correlation coefficients are shown for each comparison. 
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Materials and Experimental Procedures 
Cell Culture 
Fetal liver (FL) cells from embryonic day 13.5 to 14 (E13.5-E14) C57BL/6 mouse 
embryos were first depleted of Gr-1+, F4/80+, Ter119+, and CD19+ (“Lin cocktail 1”) 
cells using streptavidin-coupled magnetic microbeads (Miltenyi Biotec) against biotin-
conjugated antibodies. Lin-c-Kit+CD27+ multi-lineage precursors were then sorted from 
lineage-depleted FL cells by FACS and co-cultured with OP9-DL1 stromal cells as 
described previously (Taghon et al., 2005). 50~100 × 103 Lin-c-Kit+CD27+ FL cells were 
plated on OP9-DL1 monolayers in 10 cm plates in the presence of 5 ng/mL Flt3-L and 5 
ng/mL IL-7 (both from Peprotech). After 4.5 d of culture, half of the cells were harvested 
and sorted to isolate DN1 (FLDN1, Lin-c-KithiCD45+CD44+CD25-) and DN2a cells 
(FLDN2a, Lin-c-KithiCD45+CD44+CD25+) (using “Lin cocktail 2” = antibodies to Ter-
119, CD19, F4/80, Gr-1, NK1.1, CD122, CD11c, TCRγδ, TCRβ, CD3ε, CD8α). After 
8.5 d of culture, the rest of the cells were harvested and sorted for FLDN2a and DN2b 
(FLDN2b, Lin-c-KitintCD45+CD44intCD25+). The FLDN2a samples used for analysis 
were each pools of day 4.5 and day 8.5 DN2a cells in approximately 2:1 ratio. For 
subsets from adult (4-6 weeks old) thymus, wild-type C57BL/6 mouse thymi were first 
depleted with antibodies to Ter-119, CD19, F4/80, Gr-1, NK1.1, CD122, CD11b, CD11c, 
TCRγδ, TCRβ, CD3ε, CD4 and CD8α (“Lin cocktail 3”). Thymic DN3 (ThyDN3) cells 
were then sorted from lineage-depleted thymocytes as Lin-c-Kit-CD44-CD25+. Finally, to 
prepare ThyDP populations free of contaminating cells in early stages of TCR-dependent 
positive selection, while maintaining viability of these fragile cells, ThyDP cells were 
collected from TCRα-/- thymi (4-6 weeks old, The Jackson Laboratory, B6.129S2-
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Tcratm1Mom/J) by simple streptavidin-coupled magnetic microbead depletion with 
biotinylated antibodies against Ter-119, CD19, F4/80, Gr-1, NK1.1, CD122, CD11b, 
CD11c, c-Kit, CD44 and CD25. After this depletion, 90~95% of cells were CD4+CD8+. 
Antibodies used were from eBioscience and Biolegend, including anti-CD4 
(GK1.5; biotin), anti-CD8α (53-6.7; biotin), anti-CD11b (M1/70; biotin), anti-CD11c 
(N418; biotin), anti-CD19 (eBio1D3; biotin), anti-CD122 (5H4; biotin), anti-Gr1 (RB6-
8C5; biotin), anti-F4/80 (BM8; biotin), anti-TCRβ (H57-597; biotin), anti-TCRγδ 
(eBioGL3; biotin), anti-NK1.1 (PK136; biotin), anti-Ter119 (Ter-119; biotin), anti-c-Kit 
(2B8; PE, APC, biotin), anti-CD27 (LG.7F9; APC), anti-CD25 (PC61.5; APC-Alexa 
750, APC-Alexa 780, biotin), anti-CD44 (1M7; Pacific Blue, eFluor 450, biotin), anti-
CD45 (30-F11; APC), anti-CD3ε (145-2c11, PerCp-cy5.5). For detection of biotinylated 
antibodies, streptavidin–PerCp-Cy5.5 was used. 
Lineage Commitment Assay 
Samples of 25 FLDN1, FLDN2a or FLDN2b cells were each sorted into 96 well 
plates coated with either OP9-DL1 or OP9-Mig (control) monolayers in the presence of 5 
ng/mL Flt3-L, 5 ng/mL IL-7, 5 ng/mL SCF, and either 200 units/mL IL2 or 5 ng/mL 
MCSF. After 7 days of co-culture, cells were harvested and subjected to FACS analysis, 
using NK1.1 and/or Dx5 as a marker for NK progeny, CD19 as a marker for B-cell 
progeny, and CD11b/CD11c as markers for myeloid and dendritic progeny. Results are 
shown in Table S1. 
Chromatin Immunoprecipitation 
Each histone modification ChIP was generated using 5 million cells and 20 µg of 
each of the following antibodies: H3K(9,14)Ac (Millipore 06-599), H3K4me2 (Millipore 
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07-030) and H3K27me3 (Millipore 07-449). PU.1 ChIP was generated using 7.5~10 
million cells and 5µg anti-PU.1 (Santa Cruz sc-352). GATA-3 ChIP was generated using 
15~20 million cells and 2.5 µg anti-GATA-3 (Santa Cruz sc-268). In addition to FLDN1, 
FLDN2a and 2b samples, we performed PU.1 ChIP on a ThyDP sample, which naturally 
lacks PU.1 expression, as a negative control. ChIP was carried out essentially following 
the manufacturer’s protocol (http://www.millipore.com/userguides/tech1/mcproto407), 
with the exceptions that protein A or G agarose beads were replaced by anti-rabbit or 
anti-mouse secondary antibody-coupled magnetic beads (Dynabeads, pre-washed with 
1xPBS/0.5%BSA, 1 µg Ig/10 µL beads), and the pre-clear step was omitted. Independent 
biological replicates were generated for histone modification ChIP of FLDN1, FLDN2b, 
ThyDN3 and ThyDP. Different batches of histone modification antibodies (Millipore 06-
599, Millipore 07-030, Millipore 07-449) were used among biological replicates. Purified 
ChIP DNA was subjected to end repairing, adaptor ligation, PCR amplification, size 
selection by gel electrophoresis (200~300 bp, insert plus adaptor and PCR primer 
sequences) and a second round of PCR amplification to generate each ChIP DNA library 
as described (Johnson et al. 2007) (Illumina ChIP-seq sample preparation kit #IP-102-
1001). 
mRNA Purification and cDNA Library Building 
Total RNA was extracted from 2.5~20 million cells using Trizol (Invitrogen), and 
then subjected to two rounds of selection using Oligo-dT coupled magnetic beads 
(Dynabeads) according to the manufacturer’s protocol. About 100 ng polyadenylated 
mRNA per sample was obtained after double selection. Independent biological replicates 
were generated for all five populations (triplicates for FLDN2b). cDNA library building 
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was performed as described (Mortazavi et al., 2008). Briefly, RNA was fragmented to an 
average length of 200 bp by Mg2+-catalyzed hydrolysis and then converted into cDNA by 
random priming. cDNA was then subjected to end repairing, adaptor ligation ligation 
(using Illumina ChIP-seq sample preparation kit #IP-102-1001),  size selection and one 
round of PCR amplification.   
High-Throughput Sequencing 
Each ChIP DNA library or cDNA library was sequenced with the Illumina 
Genome Analyzer II and IIX following the manufacturer's protocols 
(http://www.illumina.com) (Johnson et al., 2007, Mortazavi et al., 2008).  
RNA-seq Data Analysis 
Sequence reads from each cDNA library (38 bp, single-read) were trimmed to 32 
bp long and mapped onto the mouse genome build NCBI37/mm9 using Bowtie (bowtie-
0.12.1, http://bowtie-bio.sourceforge.net/index.shtml) with setting ‘-v 2 -k 11 -m 10 -t --
best --strata’. The mappable data were then processed by the ERANGE v. 3.3 RNA-seq 
analysis program (Mortazavi et al, 2008). Assuming total transcriptional activity is 
comparable between different cell types, the obtained data (data units in RPKM, reads 
per kilobase exon model per million mapped reads) were first log2 transformed and 
linearly normalized between individual samples, then averaged among biological 
replicates or triplicates. At the same time, in order to find genes that were changed in 
expression between two populations to a statistically significant degree, ERANGE 
processed data were analyzed by the Bioconductor DEGseq program ((Wang et al., 2010) 
http://www.bioconductor.org/packages/2.6/bioc/html/DEGseq.html) (data units in RPM, 
reads per million mapped reads, method = "MARS", p < 0.001) (Figure 1A). This 
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analysis yielded 3,697 DEGseq positive genes that had more than a twofold change in 
RNA-seq reads (after normalization and averaging), either between any two successive 
stages or between FLDN1 and ThyDP, and these were defined as differentially expressed 
genes. To identify differentially regulated transcription factors, we did Gene Ontology 
analysis of this set with key term “DNA-dependent regulation of transcription” 
(GO:0006350), and the resulting list was then hand curated to remove cell surface 
receptors, cytokines, and other genes of questionable categorization. The final list used 
for alignment against our DEGseq set is presented as Table S3 part A. 
Hierarchical clustering: To determine the overall tendencies of change in gene expression 
and the connection between different populations, we hierarchically clustered RNA-seq 
data of these 3,697 selected genes from all 11 samples (using normalized data, biological 
replicates and triplicates were treated independently, Figure 1B). Hierarchical clustering 
was performed along both dimensions with sample similarities clustered first, and then 
genes. Euclidean distance and complete linkage were used (MATLAB 7.10.0). 
Separately, two-dimensional hierarchical clustering was also performed on 379 
differentially expressed transcription factors (Figure 1C). 
K-means clustering: To profile and categorize the behavior of clusters of similarly 
regulated genes during early T cell development, we first normalized individual mRNA 
data for the 3,697 selected genes by the corresponding geometric mean of five stages, and 
then performed K-means clustering analysis on the results after log2 transformation 
(Figure S5). K was set at 25 and squared Euclidean distance was used (MATLAB 
7.10.0). 
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ChIP-seq Data Analysis 
Histone Modification ChIP-seq: DNA sequence reads from each ChIP-seq library 
(single-read) were trimmed and mapped onto NCBI37/mm9 using the same setting as for 
RNA-seq data, and uniquely mapped reads were used for further analysis. The data were 
processed by the ERANGE v. 3.3 findall peak finder (Johnson et al. 2007) to identify 
enriched genomic regions. We used a stringent setting of ‘-spacing 100 -minimum 4 -
ratio 4 -minPeak 0.5 -shift learn’ for H3Ac and H3K4me2 ChIP-seq data, and a relatively 
less stringent setting of ‘-notrim -nodirectionality -spacing 100 -minimum 2 -ratio 4 -
minPeak 0.25 -shift learn’ for H3K27me3. The sequence data of the input DNA from the 
same cell type were used as background control. Since on average the total amount of 
mappable DNA reads of each H3K27me3 ChIP-seq data was about two times of that of 
each H3Ac and H3K4me2 ChIP-seq data, the minimum total DNA reads for called 
regions were comparable for all three histone modifications (that is, about minimum 60 to 
80 enriched DNA reads per region).  
All called regions (from all 27 samples) were pooled and merged if overlapping. 
Only resulting regions of at least 200 bp were considered for further analysis. This 
conservative approach treats any local change in peak height or spreading of histone 
modification as effects on a single region, thus providing a minimum estimate of the 
number of centers of regulatory change. Thus, for example, the change in shape factor of 
H3K4me2 commonly observed at active promoters is not considered to change the 
number of marked regions. We considered the positive regions overlapping ±1 kb from 
the TSSs of UCSC known genes (mm9, NCBI v.37) as promoter-proximal regions, and 
the rest as promoter-distal regions. Individual regions were then assigned to the nearest 
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genes using ERANGE (200 kb as the maximum radius). Signal densities (number of 
DNA reads) were calculated using ERANGE v. 3.3 regionCounts, for each region of 
every histone modification dataset. For global histone modification status of promoter 
regions, we expanded every transcriptional starting site (TSS) of UCSC known genes to a 
window of ±1 kb, and calculated signal densities of each TSS regions using ERANGE. 
Assuming that total DNA enrichment of the same histone marker is comparable among 
different cell types, we linearly normalized the read number (after log2 transformation) 
between samples from the same histone marker (i.e., based on slopes of correlation plots 
in Figure S1B). The mean for biological replicates was used for analysis. Since our RNA-
seq data cannot accurately distinguish among isoforms, for genes that have multiple 
alternative promoters we selected one promoter that had the highest H3K4me2 level (or 
H3Ac if all had the same level of H3K4me2). Regions (both distal and promoter regions) 
that had more than 4 RPM in either H3Ac or H3K4me2, or more than 2 RPM in 
H3K27me3 were considered as positive for the particular histone modification(s) 
(Figures 2, S2). The processed data were plotted and visualized in MATLAB. 
All RNA-seq and ChIP-seq sequencing tracks were generated in WIG file format 
and uploaded onto the UCSC genome browser for visualization. Publicly available data 
used in this study (Lin et al., 2010; Heinz et al., 2010; Wei et al., 2009) were downloaded 
as raw sequence data (http://www.ncbi.nlm.nih.gov/geo) and remapped onto 
NCBI37/mm9 using the same settings. 
PU.1 and GATA-3 ChIP-seq: Since PU.1 ChIP enriched genomic regions were in 
general narrower than histone modification enriched regions, we used a setting of “-
spacing 50 -minimum 2 -ratio 4 -minPeak 0.5 -shift learn -listPeak” for the ERANGE 
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findall peak finder. The sequence data of the input DNA from the same cell type was 
used as background control. Publicly available PU.1 ChIP-seq and input data from E2A-/- 
pre-pro B cells, mature B cells and macrophages (Heinz et al., 2010) were downloaded as 
raw sequence data (http://www.ncbi.nlm.nih.gov/geo) and remapped using the same 
setting. 
Called regions were pooled and merged if overlapping from each pair-wise or 
three-way comparison (from E2A-/- pre-pro B vs. FLDN1, B cell vs. FLDN1, 
macrophage vs. FLDN1, or FLDN1 vs. FLDN2a vs. FLDN2b). Individual regions were 
calculated for PU.1 enriched signal densities and then assigned to the nearest genes (200 
kb as the radius) using ERANGE. We next aligned the summits of all positive regions 
and calculated histone modification signal densities in a window of ±1 kb. All histone 
modification data were linearly normalized (using the parameters generated from global 
histone modification analysis). The mean for biological replicates was used for analysis. 
Scatter plots were generated and visualized in MATLAB.  
To compare differential PU.1 binding with associated differential gene expression 
and H3K4me2 enrichment during early T cell development, we divided PU.1 binding 
linked genes into four subgroups: upregulated and downregulated genes (selected from 
the differentially expressed genes group and having more than 2-fold change in 
expression from FLDN1 to FLDN2b; see “RNA-seq Data Analysis”), stably expressed 
genes (less than 2-fold change in expression between FLDN1 and FLDN2b), and silent 
genes (<1 RPKM in both stages). The changes in PU.1 occupancy and in H3K4me2 
enrichment (within ±1 kb of binding summits) between FLDN2b and FLDN1 were 
calculated and plotted separately as cumulative distribution for each group (Figure S6 
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A&B). To determine whether PU.1 binding sites linked to upregulated or downregulated 
genes were more likely differentially bound by PU.1 and enriched by H3K4me2 
compared to sites linked to stably expressed genes, two-sample Kolmogorov-Smirnov 
test was performed between stably expressed gene sites and each of the other three 
subgroups (Figure S6 A&B). 
To visualize histone modifications and degree of PU.1 occupancy surrounding the 
summits, we further expanded positive regions to a window of ±2 kb, and divided each 
window into 50 bins (80 bp each). Histone modification and PU.1 enrichment were 
calculated for each bin using the same method mentioned above. The data obtained were 
aligned with RNA-seq data of associated genes, and then hierarchically clustered (one 
dimensional clustering of binding regions; using Euclidean distance and Ward linkage) 
and visualized as heat maps in MATLAB as shown in Figure S6C-D. 
GATA-3 ChIP-seq data was processed similarly to PU.1 ChIP-seq data. To 
compare our findings with published results, raw sequence data for “CD3lo DP” cell 
samples (Wei et al., 2011) were downloaded from Gene Expression Omnibus and 
remapped using the same settings as used for our data, as described for comparing PU.1 
results (Heinz et al., 2010) above. 
De Novo Motif Analysis 
We selected the top 1,000 PU.1 enriched peaks from each of the three subgroups 
(E2A-/- pre-pro B cells high, shared, and FLDN1 high), and performed MEME analysis 
on regions ±50 bp from the peaks by ERANGE v. 3.3 using the default setting to generate 
the position specific frequency matrix (PSFM) representation of the motifs. The PSFMs 
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were mapped separately back to the three enriched regions subgroups at 85% match 
(Johnson et al. 2007).  
All 1,652 enriched GATA-3 regions (pooled from FLDN1, FLDN2b and ThyDP) 
were subjected to MEME analysis. Since the consensus sequence motifs of GATA-3 
binding sites were shorter than the ones of PU.1 binding sites, the PSFMs were mapped 
back to the 1,652 enriched GATA-3 regions and 1,652 random genomic regions at 90% 
match instead. Random genomic regions were comparable to the GATA-3 binding 
regions in both length and chromosomal distribution.  
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Figure S1. Cell purification and biological reproducibility. 
A. Lin-c-Kit+CD27+ fetal liver precursors were sorted from E13.5 to 14 C57BL/6 mouse 
embryos and co-cultured with OP9-DL1 stromal cells in the presence of IL-7 and Flt3-L.  
At day 4.5, FLDN1 cells were sorted from the co-culture as Lin-CD45+cKithiCd44+ 
CD25-, FLDN2a as Lin-CD45+cKithiCd44+CD25+. At day 8.5, FLDN2b cells were sorted 
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as Lin-CD45+cKitloCd44-CD25+, and FLDN2a cells were also collected (see experimental 
procedure).  
B. ThyDN3 cells were sorted from lineage-depleted thymocytes as Lin-c-Kit-CD44-
CD25+ (see experimental procedure).   
C. ThyDP cells were collected from B6 background TCRα-/- thymi by depletion with 
Ter-119, CD19, F4/80, Gr-1, NK1.1, CD11c, c-Kit and CD44. After depletion, 90~95% 
of cells were CD4+CD8+(see experimental procedure). Cells lacking TCRα were used in 
order to enable DP cells to be generated normally, a process dependent only on TCRβ, 
but leaving them without the capacity to undergo positive selection to any later stages of 
T-cell development. 
D. Global comparisons of RNA-seq between biological duplicates or triplicates (log2 
transformed) for individual cell populations (including FLDN1 sample I vs. II, FLDN2a 
sample I vs. II, FLDN2b sample I vs. II, FLDN2b sample II vs. III, ThyDN3 sample I vs. 
II, and ThyDP sample I vs. II). The Pearson’s correlation coefficient for each comparison 
is indicated in the insert. 
E. Global comparisons of histone modifications ChIP-seq experiments between 
biological duplicates (after log2 transformed) for individual cell populations (including 
FLDN1 experiment A vs. B, FLDN2b experiment A vs. B, ThyDN3 experiment A vs. B, 
and ThyDP experiment A vs. B). From top row to bottom are H3Ac, H3K4me2 and 
H3K27me3. The Pearson’s correlation coefficient for each comparison is indicated in the 
insert. 
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Figure S2. Global distribution of three histone modifications. 
A. Length distribution of discrete genomic regions enriched with the specified histone 
modification in at least one cell population. First, more regions were enriched with 
H3K4me2 in at least one cell population than H3Ac or H3K27me3. Second, while the 
majority of enriched regions were within 500~5,000 bp (>95% for H3Ac and H3K4me2; 
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81.5% for H3K27me3), H3K27me3 enriched regions were relatively more diverse in 
length, including some regions of much greater extent. 
B. Signal density plots of histone modifications at individual promoter-proximal or distal 
regions in each population. Signal densities were calculated for every discrete genomic 
region enriched with at least one histone modification in at least one population, then log2 
transformed and normalized (see experimental procedure). X-axis indicates H3K27me3 
value and y-axis indicates H3K4me2 value, while the color coding specifies the signal 
density of H3Ac in each element. In each stage, total regions were separated into four 
subgroups, based on the enrichment of H3K4me2 (≥4 RPM as positive) and H3K27me3 
(≥2 RPM as positive). The percentage of regions for each group is indicated in the insert.  
C. Distribution of histone modifications at the promoters with respect to transcriptional 
activity. Based on the transcriptional activity, total Refseq annotated genes were divided 
into subgroups of expressed genes (in red table, normalized RNA-seq value ≥ 1 RPKM) 
and silent genes (in blue table, normalized RNA-seq value < 1 RPKM). Each number 
indicts total amount of promoters enriched with the specified histone modification or 
combination of histone modifications. The percentage of promoters enriched with the 
specified histone modification or combination of histone modifications within the 
respective subgroup is given in the parenthesis.  
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Figure S3. Global profiles of histone modifications and gene expression at both 
promoter regions and distal regions. 
A. The normalized signal densities of histone modifications at the promoter region were 
aligned with the normalized mRNA data for each of 20,861 Refseq annotated genes, and 
one-dimensional (along genes) hierarchical clustering was performed using Ward linkage 
and Euclidean distance. 
B. Each distal region was assigned to the closest gene, and one-dimensional hierarchical 
clustering, along genes, was performed as in Figure S3A. 
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Figure S4. Dynamic histone modifications and transcription factor binding are 
linked to differentially regulated gene expression. 
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A. UCSC genome browser tracks depicting H3K4me2 and gene expression at Notch1 
locus. A Notch1 distal alternative promoter or cis-regulatory element	  (black arrow, most 
5’ component of H3K4me2 peak) activity was upregulated at DN2b and DN3 stages. 
B. UCSC genome browser tracks depicting GATA-3 binding, together with binding 
associated H3K4me2 and gene expression, at Rag1/2 loci. Black arrows indicate the DP 
specific Rag1/2 enhancer, where GATA-3 occupancy was observed at a low level in 
DN2b stage and sharply increased in DP stages, as did binding associated H3K4me2. 
Due to the strong upregulation of gene expression of Rag1 and Rag2 from DN3 to DP, 
note that in this panel the range of RNA-seq signal densities of Rag1 and Rag2 for DP 
(0.02 to 100 in red) is different from the one for other stages (0.02 to 16). 
C. UCSC genome browser tracks showing GATA-3 binding, together with binding 
associated H3K4me2 at Cd3e/d/g loci. 
D&E. UCSC genome browser tracks depicting histone modifications and gene expression 
at Il2ra (D) and Ebf1 (E) loci. 
F&G. UCSC genome browser tracks depicting PU.1 binding, together with binding 
associated histone modification(s) and gene expression (of Flt3), at Flt3 (F) and Hhex (G) 
loci. PU.1 occupancies, as well as binding associated H3K4me2, at the promoters of Flt3 
and Hhex (black arrows) decreased from DN1 to DN2a stages, and completely 
disappeared in DN2b, in parallel with the gene expression pattern of two genes (Hhex 
expression and histone modification patterns are depicted in Figure 4E). 
H&I. UCSC genome browser tracks depicting GATA-3 binding, together with binding 
associated histone modifications and gene expression, at Tcf7 (H) and Zbtb7b (I) loci. 
GATA-3 occupancy at an upstream distal region of Tcf7 (black arrow) increased from 
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DN1 to DN2b, as gene expression of Tcf7 was upregulated from DN1 to DN2b. Although 
repressed by H3K27me3 in DN2b and DP (pre-positive selection), Zbtb7b upstream 
distal region was constantly bound by GATA-3 (black arrow) in both stages. Note that 
the range of RNA-seq signal densities of Tcf7 for DP (0.02 to 80 in red) is different from 
the one for other stages (0.02 to 40). 
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Figure S5. K−means clustering for differentially expressed genes. 
3,697 differentially expressed genes were subjected to K-means clustering analysis that 
inferred to 25 differentially expressed patterns (see Experimental Procedures).  Error bar 
represents the standard deviation of biological replicates or triplicates of individual genes 
at each stage. The genes in each cluster are listed in order in Table S4A. 
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Figure S6. PU.1 occupancy associated with epigenetic modifications and gene 
expression during early T cell development.	  
A. Cumulative distributions of changes in PU.1 occupancy between FLDN2b and 
FLDN1 among promoter-proximal sites (top) and promoter-distal sites (bottom). The 
total PU.1 binding sites in DN cells (as depicted in Figure 5B) were separated in two 
groups, promoter-proximal sites ( ≤1 kb from nearby TSS) and promoter-distal sites (>1 
kb from nearby TSS). Based on the expression patterns of binding linked genes from 
FLDN1 to FLDN2b, each group was then divided into 4 subgroups: downregulated gene 
sites (linked to genes  ≥2x downregulated, blue), upregulated gene sites (linked to genes 
≥2x upregulated, red), stably expressed gene sites (linked to genes with <2x change in 
expression, green) and silent gene sites (linked to genes with <1 RPKM in both stages, 
black). Binding sites linked to downreulated genes, both distal and proximal, tend to lose 
PU.1 occupancy more rapidly than other groups of sites. K-S test was performed between 
stably expressed gene sites and each of the other three subgroups. The number of sites in 
each group and p value for each comparison are indicated in parentheses. 
B. Cumulative distributions of changes in PU.1 binding associated H3K4me2 between 
FLDN2b and FLDN1 among promoter-proximal sites (top) and promoter-distal sites 
(bottom). H3K4me2 signal densities were calculated within ±1 kb of the summit of a 
given PU.1 bound region (as depicted in Figure 5B). K-S test was performed between 
stably expressed gene sites and each of the other three subgroups as described in S6A. 
The number of sites in each group and p value for each comparison are indicated in 
parentheses. 
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C1&2. Heat maps of PU.1 occupancy and distribution of H3Ac, H3K4me2 and 
H3K27me3 surrounding ±2 kb of the binding summits for promoter-proximal regions 
(see experimental procedures). The PU.1 binding sites in DN cells were divided into four 
subgroups based on linked gene expression patterns as described in S6A. As comparison, 
a separate group of heat maps for promoter-proximal regions that were selected for much 
greater PU.1 binding in E2A-/- cells than in early T-lineage cells (as in Figure 5) are 
included.  
D. Heat maps of PU.1 occupancy at promoter-distal regions are shown as in C1&2, 
correlated with distribution of H3Ac, H3K4me2 and H3K27me3 surrounding ±2 kb of 
the binding summits (see Experimental Procedures). RNA expression heat maps refer to 
the nearest linked gene and a single gene can be represented by more than one PU.1-
bound distal region. The PU.1 binding sites in DN cells were divided into four subgroups 
as described in panel A. As comparison, a separate group of heat maps for promoter-
distal regions that were specific for PU.1 binding in E2A-/- cells (as in Figure 5) are 
included.  
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Figure S7. Characterization of sites of GATA-3 binding in early developing T cells. 
 
?? ?? ?? ?? ?? ! ? ? ? ? ?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
 
 
????????????????????????????????????
????????????????????????????????
??????????????????????????????????????
???????????????????????????????????
 
 
?? ?? ?? ?? ?? ! ? ? ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ? ? ?
?? ?? ?? ?? ?? ! ? ? ? ? ?
??
??
???
???
??
??
??
??
??
 
?? ?? ?? ?? ?? ! ? ? ? ? ?
 
 
 
?? ?? ?? ?? ?? ! ? ? ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ? ? ?
??????????????????????????
???????????
????????????????????? ?????????????? ????????
????????? ????????????????
???????????????????
????????? ????????????????
???????????????????
??
?
?
?
??
?
?
??
?? ?? ?? ?? ?? ! ? ? ?
?
 
 
?? ?? ?? ?? ?? ! ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ?
 
 
?? ?? ?? ?? ?? ! ? ? ?
??
??
???
???
??
??
??
??
??
???????????????????????????
???????????
????????????????????? ?????????????? ????????
????????? ?????????????????
???????????????????
????????? ?????????????????
???????????????????
??
?
?
?
??
?
?
??
?? ! ? ??
??
!
?
??
?????????????????????????????
???????????
??
??
??
??
??
??
??
??
??
???
??
??
??
???
??
??
??
??
????????
!
"
#
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
!
!"?
!"?
!"?
!"?
!"?
!"#
!"$
!"%
!"&
?
	   130	  
A. Comparisons of GATA-3 DNA binding site distributions in ThyDP (Tcrα-/- DP, using 
Santa Cruz sc-268 antibody) and CD3lo DP (using BD biosciences #558686 antibody) 
(Wei et al. 2011). Pearson’s correlation coefficient (r) is indicated. 
B. Cumulative distributions of H3K4me2 enrichment over genomic regions within ±1 kb 
of PU.1 binding sites and GATA-3 binding sites in FLDN1 (top panels) and FLDN2b 
(bottom panels) cells. In each stage, positive binding sites (≥2 RPM of PU.1 or GATA-3 
enrichment, see table S5 or S7 respectively) were divided into two groups, promoter-
distal sites and promoter-proximal sites. Each group of binding sites was further divided 
into two subgroups based on the expression level of binding associated genes (expressed 
and silent). Since PU.1 tends to bind at multiple sites of a single gene locus, it is possible 
that binding sites with low or no histone modifications of a particular gene locus are 
nonfunctional. PU.1 binding sites with the highest H3K4me2 enrichment at each gene 
locus were selected (sites in promoter-distal regions and promoter-proximal regions were 
selected separately), and plotted accordingly. 
C. Cumulative distributions of H3K27me3 enrichment over genomic regions within ±1 
kb of PU.1 binding sites and GATA-3 binding sites in FLDN1 (top panels) and FLDN2b 
(bottom panels) cells. In each stage, positive binding sites were divided similarly as in 
Figure S7B. 
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Supplementary Tables 1-7 
Table S1. Lineage commitment status measurements for FLDN cells differentiated in 
vitro (see supplementary files). 
Table S2. Genome-wide quantitation of histone modifications and gene expression (see 
supplementary files). 
Table S3. Dynamic expression pattern of transcription factors during T-lineage 
commitment (see supplementary files). 
Table S4. K-means clustering for differentially expressed genes and histone marking and 
transcriptome profiles of hematopoiesis genes (see supplementary files). 
Table S5. Genome-wide PU.1 binding from FLDN1 to FLDN2b (see supplementary 
files). 
Table S6: Distribution of PU.1 binding sites among differentially expressed gene clusters 
(see supplementary files). 
Table S7. Genome-wide GATA-3 binding in FLDN1, FLDN2b and ThyDP (see 
supplementary files). 
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Chapter 3 
A Gene Network Involving Bcl11b, Notch1 and GATA-3 
Regulates T-cell Lineage Specification and Commitment  
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Abstract	  
Bcl11b is crucial for the proper T-cell lineage commitment. Bcl11b deletion leads to a 
developmental block at uncommitted DN2a stage with enhanced NK potential and 
retained stem cell/progenitor-linked properties. Using global gene expression profiling, 
we show that Bcl11b-deficient pro-T cells are able to initiate T-cell specification but fail 
to complete the whole process, and Bcl11b is essential to silence progenitor- and 
alternative lineage-associated gene program. Our data reveal that Notch1 and GATA-3 
are dysregulated in the absence of Bcl11b, with Notch1 being downregulated and GATA-
3 being upregulated. Furthermore, several NK gene loci that are upregulated specifically 
in Bcl11b-deficient DN2a cell are bound by GATA-3. Taken together, our data suggest 
cooperative interplay between Bcl11b, Notch1 and GATA-3 is required for T-lineage 
commitment.	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INTRODUCTION 
In mammalian, multipotent progenitors in bone marrow migrate into thymus and 
give rise to T cells. The thymus is the major organ where T-cell differentiation is initiated 
and nourished. It supplies many T-lineage promoting cytokines and ligands, including 
Notch1 ligand Delta-like 4. The interaction between Notch1 expressed on thymocytes 
and Delta-like 4 expressed on the thymic epithelium is a pivotal driving force in 
supporting pro-T cell survival, proliferation, and differentiation during early stages of T-
lineage development up to and including the β-selection (Sambandam et al., 2005; 
Yashiro-Ohtani et al., 2010). Ectopic expression of Notch intracellular domain (NICD) 
promotes thymic-independent T-cell development (Yashiro-Ohtani et al., 2010). 
However, Notch-Delta signaling by itself is not sufficient; additional factors, including 
Myb, Runx1, TCF-1, E protein E2A and HEB, Gfi1, Ikaros, GATA-3 and Bcl11b, are 
required to coordinate with Notch-Delta signaling in directing T-lineage commitment 
(Ikawa et al., 2010; Rothenberg et al., 2010; Weber et al., 2011).  
Among the aforementioned factors, Bcl11b is one of a few factors that are 
exclusively expressed in T-lineage of all hematopoietic lineages. It is absent in ETP 
(DN1), and first turns on at relatively low level in DN2a cells. Bcl11b is one of the very 
few transcriptional regulators that are strongly upregulated (>50x) during the 
commitment from DN2a to DN2b, and its expression sustained at fairly stable level 
onward throughout T-cell development (Li et al., 2010b) (see Chapter 2). The unique 
expression pattern suggests that Bcl11b is not required for the initiation of T-lineage 
specification, but, rather, a major player during the commitment process. T-lineage 
commitment is coupled with eliminating alternative lineage potentials as well as 
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progenitor-associated stem-ness characteristics. The DN2a to DN2b transition is the first 
critical checkpoint for T-cell development, when non-T-fate choices and self-renewal 
potential are terminated (Rothenberg et al., 2010). Studies from our lab and others have 
shown that conditional deletion of Bcl11b in uncommitted pro-T cells in vitro arrests 
cells at DN2a-like stage with increased alternative lineage potentials ⎯ in particular NK 
potential — that are less sensitive to the Notch1 inhibition (Ikawa et al., 2010; Li et al., 
2010a; Li et al., 2010b). Intriguingly, Bcl11b-deficient cells also fail to completely 
silence stem cell/progenitor-associated program, which, as result, possibly hinders the 
ability of Bcl11b-deficient cells to further differentiate along αβ T-lineage pathway 
despite the fact that some T-lineage specification genes appear expressed at compatible 
levels with those in wild-type DN2b cells (Li et al., 2010a).  
To assess the global defect in T-lineage differentiation program caused by Bcl11b 
deletion, we performed RNA-seq analysis on in vitro derived Bcl11b-deficient DN2a-like 
cells. Consistent with the c-KithiCD25+ DN2a-like cell surface phenotype, the global gene 
expression profiles indicated Bcl11b-deficient DN2a cells was more closely related to 
wild-type DN2a cells than DN2b cells, implying Bcl11b is absolutely required for T-cell 
precursors to successfully pass the commitment checkpoint. Additionally, we identified 
two transcription factors essential for T-lineage development — Notch1 and Gata3 — 
that were abnormally regulated in the absence of Bcl11b. Loss of Bcl11b led to 
upregulation of GATA-3 and downregulation of Notch1. Our data suggest that Bcl11b is 
an essential connecting node in the regulatory network that controls T-lineage 
commitment, and removal of Bcl11b causes the collapse of the topology of the network.  
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RESULTS 
Global Expression Profile of Bcl11b-Deficient DN2a-Like Cells 
Bcl11bfl/fl prethymic precursors was deleted for Bcl11b using retroviral transduced 
Cre recombinase, and grown in vitro on OP9 stromal cells expressing Notch ligands 
(DL1 or DL4) in the presence of IL-7 and Flt3-L (Li et al., 2010a). As expected, after 7 to 
9 days of culture, while the majority of wild-type control cells (>60%) differentiated into 
DN2b stage (Lin-c-Kitlo/-CD25+), most Bcl11b-deficient cells stayed at DN1-like (Lin-c-
KithiCD25-, ~18%) or DN2a-like (Lin-c-KithiCD25+, ~69%) stages (Figure 1A). We 
noticed that while c-Kit expression was linearly correlated with CD44 surface expression 
in wild-type Lin- DN cells, CD44 level was no longer coupled with c-Kit surface 
expression in Bcl11b-deficient Lin- DN cells; more than half of c-Kithi Bcl11b-deficient 
Lin- DN cells were CD44- (Figure 1A). And in agreement with previous studies, deletion 
of Bcl11b gave the cells survival or growth advantages. Single cell analysis confirmed 
that, starting with the same number of precursors and under the comparable culture 
conditions, Bcl11b-deficient cells gave rise to more DN2a-like cells than wild-type 
controls (Li et al., 2010a) (data not shown). 
To identify major changes in gene expression directly or indirectly caused by 
Bcl11b deletion, RNA-seq was performed for Bcl11b-deficient Lin-c-KithiCD25+ DN2a-
like cells and the wild-type Lin-c-KitloCD25+ DN2b cells. As a comparison, RNA-seq 
data from fetal liver precursor derived DN2a cells was also included (see Chapter 2). We 
used RNA-seq programs ERANGE and DEGseq to evaluate differentially expressed 
genes between Bcl11b-deficient DN2a cells with either wild-type DN2a or DN2b cells. 
The analysis generated total 1,746 genes that were statistically	  significantly changed in 
	   137	  
expression between at least one pair of cells, with 900 genes between Bcl11b-deficient 
DN2a and wild-type DN2a and 1,146 genes between Bcl11b-deficient DN2a	  and wild-
type DN2b (p < 0.001 &  ≥2x change in expression, Figure 1B). As expected many T-
lineage specification regulators that are expressed rather constantly during the 
commitment in wild-type cells, such as Tcf7, Runx1/2/3, Ikaros, Myb and Tcfe2a, were 
not affected by Bcl11b deletion (Li et al., 2010a). And, more genes were upregulated than 
downregulated in the absence of Bcl11b, consistent with the repressive function of 
Bcl11b suggested by biochemical studies (Cismasiu et al., 2005). On the other hand, 202 
genes, or 10% of differentially expressed genes, were statistically significantly 
upregulated in Bcl11b-deficient DN2a cells against those in both wild-type DN2a and 
DN2b cells, whereas only 46 genes were downregulated in Bcl11b-deficient DN2a 
against both wild-type counterparts (Figure 1B).	   It is possible that some differences 
between wild-type DN2a cells and its knockout counterparts were due to the low level of 
Bcl11b protein present in wild-type DN2a cells. Nevertheless, among the genes 
upregulated in Bcl11b-deficient cells, some are normally kept silence or expressed at 
background level throughout early T-cell development; the elevation of these genes 
cannot be attributed solely to Bcl11b deletion, and additional mechanism(s) are involved 
(Rothenberg et al., 2010).  
While surface markers suggested that Bcl11b-deficient cells were blocked at 
DN2a stage, the global gene expression profiling showed that, in the absence of Bcl11b, a 
considerable number of genes departed from their normal expression levels at the DN2a 
stage, and some were actually expressed at the levels that are considered as DN2b-like, 
implying that a part of T-lineage specification and commitment program is Bcl11b-
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independent (Li et al., 2010a) (see below). Nevertheless, the gene profile of Bcl11b-
deficient DN2a-arrested cells resembled to the profile of wild-type DN2a more than that 
of DN2b, as indicated by the difference distribution plot and the hierarchical clustering 
(Figure 1C & D). Expression levels of the 1,746 differentially expressed genes in Bcl11b-
deficient cells were in general deviate less from those in control DN2a than those in 
DN2b (Figure 1C; Kolmogorov-Smirnov two-sided test; p = 4.18e-22). Furthermore, the 
hierarchical clustering also suggests Bcl11b-deficient DN2a-like cells are more closely 
related to wild-type DN2a than DN2b (Figure 1D). 
Distinct Expression Patterns of Dysregulated Genes in Bcl11b-Deficient Cells	  
In previous studies from our lab, gene expression profiles of Bcl11b-deficient 
DN2a-like cells were analyzed by quantitative PCR with emphasis on a group of genes 
related to T-lineage specification, and alternative lineages and stem cell/progenitor-
associated genes. In Bcl11b-deficient cells, many genes known to regulate T-lineage 
specification were expressed at the comparable levels as those in the wild-type 
counterparts. Some alternative lineage-associated genes, specifically NK-promoting 
genes, however, were abnormally augmented (Li et al., 2010a). Furthermore, Bcl11b-
deficient cells failed to silence a subset of genes related to stem-cell self-renewal 
potential (Li et al., 2010a). To determine how genes are dysregulated due to the absence 
of Bcl11b, we aligned the three populations in the order of DN2a, Bcl11b-deficient 
DN2a-like and DN2b, and performed K-means clustering for the 1,746 differentially 
expressed genes (Figure 2A and Table S1). Based on the result, we divided genes into 
four distinct subgroups: (1) “DN2a-like” genes, which were expressed at levels more like 
those in wild-type DN2a than those in DN2b cells (in C7 and part of C3; Figure 2A); (2) 
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“DN2b-like” genes, genes whose expression were closer to DN2b than DN2a cells (in C1 
and C5; Figure 2A); (3) “intermediate” genes, genes whose expression levels lay 
somewhere in between those of DN2a and of DN2b (in part of C3 and C8; Figure 2A); 
and (4) “Bcl11b-deficiency-specific upregulated” genes, genes that were substantially 
upregulated in Bcl11b-deficient cells compared to those in both DN2a and DN2b (in C2, 
C6 and part of C4; Figure 2A). Although as mentioned earlier 46 genes were specifically 
downregulated in Bcl11b-deficient cells against those in both wild-type DN2a and DN2b 
(Figure 1B), majority were more decreased compared to those in DN2b than those in 
DN2a and were included in cluster C7 or C8 (Figure 2A).  
T-lineage commitment encompasses gradual exclusion of alternative lineage 
potentials and stepwise gain of T-cell identity. This process is reflected by the broad 
repression of progenitor- and alternative lineage-associated genes, as well as the rapid 
induction of T-cell identity genes (see Chapter 2). In wild-type cells, genes associated 
with progenitor-cells and alternative lineages are expressed exclusively in DN1 and 
DN2a stages, whereas T-cell signature genes are either sharply upregulated from DN1/2a 
to DN2b, or stably expressed throughout early T-cell development. Interestingly, Genes 
from these two categories were found in all four aforementioned groups in Bcl11b-
deficient DN2a cells (Figure 2B). For example, “DN2a-like” genes include genes from 
both categories. The first one includes Kit, Bmi1, Mpo and Il7r (in C3) — genes that are 
functionally implicated in the maintenance of the progenitors or the development of 
alternative lineages, and may help Bcl11b-deficient DN2a survive and proliferate. The 
latter one includes Ptcra, Spib, Lck, Gfi1, Notch3, and Eva1 (in C7) — genes that are 
involved in T-cell specification or provide essential signaling for cell development. These 
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T-cell genes were not upregulated in Bcl11b-deficient DN2a cells compared to wild-type 
DN2b cells. During early T-cell development, Il7r expression increases from DN1 to 
DN2a/b, and then quickly drops after DN2b stage (see Chapter 2). IL-7 signaling is 
required for pro-T cell survival and proliferation. However, enhanced or persisted IL-7 
signaling has been shown to arrest early T-cell development at pre-committed stage 
through a Bcl11b-dependent mechanism (Ikawa et al., 2010). Another cell surface 
receptor gene Eva1, encoding Epithelial V-like Antigen 1, has been suggested to play an 
important role in T-lineage commitment (Iacovelli et al., 2009). Normally, Eva1 is 
actively repressed in DN1 and DN2a stages, and transiently upregulated in DN2b and 
DN3 stages, and then repressed again afterward (see Chapter 2). In the absence of 
Bcl11b, both Il7r and Eva1 stayed as “DN2a-like”, which might contribute to the 
developmental block caused by Bcl11b deletion. On the other hand, despite being 
provided with Notch-Delta signaling for the same length of time as wild-type DN2b cells, 
Bcl11b-deficient cells failed to fully induce Ptcra, a direct target of Notch, as wild-type 
DN2b cells normally do. This result suggests that Notch-Delta signaling was 
compromised in the absence of Bcl11b.  
Likewise, “DN2b-like” genes also include both progenitor/disparate lineage-
linked genes, such as Mycn and Erg (in C1), and T-lineage specification genes, such as 
Ccr9, TcrgC, Itk, Cd3g, Rag1, Lef1 and Ets1 (in C5) (Figure 2B). The DN2b-like 
expression of TcrgC and Rag1 is consistent with the less pronounced γδT potential defect 
of Bcl11b-deleted pro-T cells observed both in vivo and in vitro (Wakabayashi et al., 
2003; Li et al., 2010a). To make things more complicated, one of aforementioned 
“DN2a-like” genes Sox13 was not fully activated due to the loss of Bcl11b (Figure 2B). 
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Sox13 is a high- mobility group (HMG) transcription factor that promotes γδT 
differentiation but inhibits abT cells (Melichar et al., 2007). This may help explain why 
Bcl11b-deficient pro-T cells are not as competent in making γδT cells as their wild-type 
counterparts either (Li et al., 2010a). 
The “intermediate” genes were markedly downregulated or upregulated in 
Bcl11b-deficient DN2a cells compared to those in the wild-type DN2a cells, but failed to 
reach the DN2b level (Figure 2B). This result implies the regulatory apparatus for these 
genes could be initiated without the involvement of Bcl11b, however, at a critical point 
between DN2a and DN2b the input from Bcl11b becomes absolutely essential. This 
group of genes once again includes a few progenitor- and/or alternative lineage-
associated genes, such as Tal, Gfi1b, Sfpi1 and Bcl11a (in C3), and a cohort of T-cell 
identity genes, such as Cd2, Cd3d, Cd3e, Cd247, Dntt, Zap79, Thy1 and Egr1 (in C8), 
many of which are involved in the assembly of TCR complex. 
One profound defect in Bcl11b-deleted T-cell progenitor is the increased NK 
lineage potential. Many NK-lineage signature factors are abnormally augmented in 
Bcl11b-deficient cells even before these cells actually differentiate into NK-like cells (Li 
et al., 2010a; Li et al., 2010b). Indeed, a number of NK genes, such as Id2, Zbtb16, Nfil3 
and Il2rb, were found in the last group of genes, the “Bcl11b-deficiency-specific 
upregulated” genes. As discussed earlier, Nfil3 and Il2rb are either silent or expressed at 
the background level in both wild-type DN2a and DN2b cells, as well as in DN1 cells 
where Bcl11b is not expressed (see Chapter 2). Thus, the loss of Bcl11b by itself is not 
sufficient to increase access to NK program; additional players are likely involved. 
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Taken together, the global expression profiling showed that loss of Bcl11b 
uncoupled several components of T-lineage commitment process. With sustained Notch-
Delta signaling Bcl11b-deficient pro-T cell were able to initiate T-cell specification 
program. However, it appeared that Bcl11b was required for the completion of 
specification (Rothenberg et al., 2010). Furthermore, Bcl11b was absolutely essential to 
silence stem cell/progenitor- and alternative lineage-associated expression programs, 
thus, without it pro-T cells were trapped in a DN2a-like immature state (Rothenberg et 
al., 2010). 
Normal Expression of Notch1 and Notch3 during Commitment Requires Bcl11b  
Although Notch-Delta signaling is the main driving force for T-lineage 
specification, our data suggested that in the absence of Bcl11b, Notch-Delta signaling 
failed to advance T-lineage program beyond the commitment. Many known Notch 
targets, such as Hes1, Tcf7 and Cd25, were apparently not affected by the loss of Bcl11b. 
Nevertheless, one Notch function indicator, Ptcra, failed to properly respond to the long-
term sustained Notch-Delta signaling that is capable of inducing Ptcra in normal DN2b 
cells. Another Notch downstream target Dtx1 (in C1) was also substantially 
downregulated in Bcl11b-deficient DN2a cells compared to that in wild-type DN2a cells 
(Figure 2B). One possibility is that Bcl11b is a potent downstream mediator for part of 
Notch signaling pathway during the commitment (Rothenberg et al., 2010).  
Another plausible explanation is Notch signaling itself was impaired by the loss 
of Bcl11b. Although still being expressed, both Notch1 and, to lesser extent, Notch3 were 
downregulated in Bcl11b-deficient cell compared to those in the wild-type counterparts 
(Notch1 is one of 46 Bcl11b-deficiency-specific downregulated genes, with more than 2x 
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decrease in mRNA level compared to both wild-type DN2a and DN2b) (Figure 2B & 
3A). Notch signaling has been suggested to be a primary activator of Bcl11b expression 
(Tydell et al., 2007; Li et al., 2010b). Conceivably, a positive feedback loop may arise 
between Notch1 and Bcl11b during the normal T-cell commitment.  
Gata3 is Upregulated in the Absence of Bcl11b 
In striking contrast, GATA-3, a T-cell-specific transcription factor, was one of the 
202 genes that were augmented only in Bcl11b-deficient cells. To test whether the 
upregulated GATA-3 expression might contribute to some of the abnormalities in	  
Bcl11b-deficient cells, we performed ChIP-seq analysis to survey global GATA-3 
occupancy in Bcl11b-deficient DN2a cells. Intriguingly, of 202 “Bcl11b-deficiency-
specific upregulated” genes, 50 genes (~25%) were bound by GATA-3 in Bcl11b-
deficient DN2a cells. These genes include Zbtb16, Il2rb, Id2, Zbtb7b, Cpa3, Ikzf2 and 
Gata3 itself (Figures 2B & S1; Table S2). Increase in CD4SP gene Zbtb7b and mast cell 
gene Cpa3 was not unexpected; these two have been shown as direct downstream targets 
of GATA-3, and either can be induced by exogenous expression of GATA-3 (Taghon et 
al., 2007) or requires GATA-3 for normal expression (Wang et al., 2008). In addition, the 
result suggests that, in the absence of Bcl11b GATA-3 may directly upregulated Zbtb16, 
Il2rb and Id2, factors that favor NK-lineage differentiation. The seven aforementioned 
GATA-3 targets are perfectly bound by GATA-3 in wild-type DN2b (see Chapter 2; 
Figure S1). All but Il2rb and Zbtb7b are expressed at moderate level in the wild-type 
counterparts (see Chapter 2; Figure S1). Thus, under normal condition these genes are 
accessible to GATA-3, as well as to the transcriptional apparatus. It is possible that in 
wild-type pro-T cell Bcl11b directly or indirectly controls the transcriptional activities of 
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these genes at the physiological levels that actually help modulate T-lineage commitment 
program. Taking away of Bcl11b not only unleashes Gata3, but also removes the 
inhibitory mechanism of NK-lineage program mediated by Bcl11b, which is in turn 
reinforced by GATA-3.  
Compelling evidence has shown that transcription factor global binding is largely 
cell type/stage-dependent (Ghisletti et al., 2010; Heinz et al., 2010; Lin et al., 2010; 
Treiber et al., 2010; Wei et al., 2011). To exclude the possibility that Bcl11b is so 
essential for maintaining T-cell identity that loss of it might have created a catastrophic 
effect on the cellular state including epigenetic landscape such that GATA-3 is no longer 
capable of finding its proper targets, we compared the global GATA-3 occupancy in 
Bcl11b-deficient DN2a-like cells with that in the wild-type cells generated from previous 
study (Figure 3D). Our data showed that increased GATA-3 did not increase the total 
number of GATA-3 bound sites in Bcl11b-deficient DN2a (Table 2). Moreover, GATA-3 
global occupancy in Bcl11b-deficient DN2a-like cells was better correlated to that in 
wild-type DN2b than that in either DN1 or DP cells (r = 0.51, 0.38, and -0.015, 
respectively; Figure 3C). Complementary to the gene profile analysis, this result strongly 
indicates although T-lineage commitment profoundly depends on Bcl11b, the deletion of 
Bcl11b does not severely alter pro-T cell’s identity. 
DISCUSSION 
T-lineage differentiation is regulated by a gene network consisting of multiple T-
specific and non-T-specific regulators. We have shown here while not being involved in 
the initiation of T-lineage program, T-specific factor Bcl11b is indispensible for T-cell 
precursors’ ability to pass the commitment checkpoint en route to become fully 
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functional T cells. When Bcl11b was deleted before pro-T cells had any chance to 
encounter it, the development was blocked at a DN2a-like stage with the presence of 
Notch-Delta signaling, when Bcl11b is normally in the process of being rapidly 
upregulated. The developmental block occurs before the commitment, as reflected by the 
enhanced NK potential, sustained progenitor-associated program and incomplete T-cell 
specification process. 
Notch-Delta signaling is the central driver for the early T-cell development. Our 
genome-wide gene expression analysis suggests that Notch pathway was compromised 
due to the loss of Bcl11b, highlighted by the substantial reduction in Notch1 and Notch3 
mRNA expression, failure to maintain Dtx1 expression, and lack of proper Ptcra 
upregulation. In contrast, many known T-lineage differentiation regulators, such as TCF-
1, Myb and E2A, were not affected in the absence of Bcl11b. The undermined Notch 
signaling therefore was one likely reason that Bcl11b-deficient pro-T cells were unable to 
complete the T-lineage specification despite being on OP9-DL culture for the same 
length of time as the controls. On the other hand, NK and myeloid cells have been shown 
to arise more robustly from Bcl11b-deficient cells if being transferred to OP9 control 
culture or treated with γ-secretase inhibitor (Li et al., 2010a). Together with the fact that 
no B-cell potential was observed in Bcl11b-deficient cell, these evidences signify that 
although being weakened, Notch-Delta signaling or its downstream mediator(s) is still 
able to partially restrain the access of pro-T cell to disparate lineages.  
That being said, one cannot exclude the possibility of Bcl11b directly involving 
T-cell specification process. Normally Bcl11b mRNA is not detectable in DN1 stage, and 
only at modest level in DN2a stage. Bcl11b is sharply upregulated from DN2a to DN2b, 
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which is accompanied by the T-lineage commitment. Deletion of Bcl11b for most part 
does not prevent the initiation of T-lineage specification program. Nevertheless, without 
Bcl11b, T-lineage specification program losses the momentum to continue. It is possible 
that there is a critical point between DN2a and DN2b where Bcl11b reaches certain level 
and becomes absolutely necessary, and lack of it will halt the program.  
Another notable defect caused by Bcl11b deletion is the enhanced NK potential in 
pro-T cells. We have pinpointed here GATA-3 was upregulated in Bcl11b-deficient pro-
T cells, and increased GATA-3 in response to Bcl11b deletion might impede T-cell 
development by promoting NK-like gene program. Like Bcl11b, GATA-3 is one of the 
most T cell-specific transcription factors. GATA-3 function in early T-cell development 
is context and dosage-dependent. Germline deletion or conditional knockout of GATA-3 
in multipotent progenitors blocks T-cell development at DN2a stage (Rothenberg and 
Scripture-Adams, 2008). Paradoxically, instead of enhancing T-cell develpmental 
progression, GATA-3 in DN2a stage either blocks cell survival when Notch-Delta 
signaling is activated, or promotes mast cell differentiation under non-T-cell permissive 
condition (Taghon et al., 2007). Interestingly, GATA-3 has been shown to directly 
engage in multiple aspects of NK development. GATA-3 is required for generating 
thymus-derived NK cells, which uniquely express both GATA-3 and IL7r (Vosshenrich 
et al., 2006). GATA-3 is also important for peripheral NK cell maturation (Samson et al., 
2003). All of these findings suggest that GATA-3 is a link closely connecting T and NK 
programs. With the exception of Cpa3, many mast cell-associated genes that in previous 
study response rapidly to the exogenous GATA-3, such as Gata1, Gata2 and Mitf 
(Taghon et al., 2007), were not induced in this Bcl11b-deficient context. One reasonable 
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explanation is that GATA-3 level is not high enough to initiate mast cell program in 
Bcl11b-deficient cells, whereas, on the other hand, the moderate elevation of GATA-3 in 
the absence of Bcl11b may help enhance NK potential by maintaining or even 
upregulating NK-associated gene expression program. Thus, our data suggest the dosage 
dependency of GATA-3 is rather sophisticated than previously thought. It is possible that 
different levels of GATA-3 dictate the passes to different lineages, including T, NK and 
mast cell, in a context-dependent manner. Since GATA-3 can be expressed in much 
higher level in peripheral T helper 2 cells compared to thymocytes (Asnagli et al., 2002), 
there must exist an inhibitory mechanism(s) to tightly control GATA-3 expression level 
in pro-T cells. Deletion of Bcl11b could partially liberate Gata3 from the transcriptional 
inhibition.  
Again, it is unlikely that the upregulation of NK program is a merely a by-product 
of Bcl11b deletion. Exogenous expression of GATA-3 appears unable to increase Id2 
expression in the presence of Bcl11b (Taghon et al., 2007). In addition, while ~20% 
Bcl11b-deficient specifically upregulated genes were directly bound by GATA-3, they 
only counted for ~5% of the total GATA-3 target in Bcl11b-deleted DN2 cells. For 
instance, although GATA-3 bound to Tcf7 and Tcfe2a in both wild-type and knockout 
cells as indicated by ChIP-seq (Table S2; see Chapter 2), no significant impact had been 
observed for the mRNA expression of either genes in Bcl11b-deficient cells. As a result, 
imbalanced E2A (encoded by Tcfe2a) and Id2 could help divert T-cell development 
toward NK pathway (Boos et al., 2007). Collectively, these observations suggest that 
besides keeping Gata3 expression in check, Bcl11b may add an additional layer of 
safeguard to specifically block the access of pro-T cell to NK lineage.  
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In contrast to the developmental arrest, our analyses imply that the loss of Bcl11b 
does not dramatically change pro-T cell cellular status at least in the short-term in vitro 
cultured cells (10~14 days). This may due to the fact that most T-lineage regulators, such 
as TCF-1 and E2A, were largely unaffected by the loss of Bcl11b. In the absence of 
Bcl11b these regulators collaborated with the weakened but not completely demolished 
Notch signaling to maintain T-cell identity, yet failed to push T-lineage differentiation 
forward to pass the commitment. 
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METHODS 
Cell Culture 
In vitro tracking development of Bcl11b-deficient cells was performed as 
described (Li et al., 2010a). Briefly, fetal liver (FL) cell samples (E13.5) from Bcl11bfl/fl-
ROSA26R-YFP	  or C57BL/6-ROSA26R-YFP mouse embryos were first depleted of cells 
positive for Ter119, CD19 and Gr1 by magnetic selection. c-Kit+CD27+ multi-lineage 
precursors were then sorted from lineage-depleted FL cells by FACS and retrovirally 
transduced with recombinase Cre. Treated precursors were co-cultured with OP9-DL1 
stromal cells in the presence of 5 ng/mL each of Flt3L, IL-7 and SCF for 24 hours. 
Successfully transduced cells were sorted for YFP expression together with lymphoid 
progenitor-enriched phenotype (c-Kit+CD27+) and returned to the OP9-DL1 or OP9-DL4 
co-culture. After 10~14 days of culture, the cells were harvested and sorted for DN2a 
(YFP+c-KithiCD45+CD25+Lin-) from Bcl11bfl/fl and DN2b (YFP+c-Kitint 
CD45+CD25+Lin-) from C57BL/6. 
Chromatin Immunoprecipitation; mRNA Purification and cDNA Library Building; 
High Throughput Sequencing; and ChIP-seq and RNA-seq Data Analysis 
All were performed as described (see Chapter 2). 
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Figure 1. Comparison of global expression profiles between Bcl11b-deficient DN2a-
like cells and the wild-type counter parts.	   
A. Flow cytometric analysis of fetal liver precursors in vitro derived pro-T cells after 9 
days of OP9-DL1 or DL4 co-culture. Left panels are wild-type control, and right panels 
are Bcl11b-deleted cells. 
B. Pair-wise comparisons in gene expression between Bcl11b-deficient DN2-like cells 
(Bcl11b-/-DN2a) and either wild-type DN2a (Bcl11b+/+DN2a) or wild-type DN2b 
(Bcl11b+/+DN2b). Statistically significantly changed genes were defined by DEGseq (p 
< 0.001, ≥2x change in expression).  
C. Difference in expression (log2(fold-change)) of individual differentially expressed 
genes between Bcl11b-deficient cells and either wild-type DN2a or DN2b cells were 
calculated and plotted. Each colored dot represents one gene. Dashed line indicates where 
the median (in parenthesis) of each data set is. Difference in expression between Bcl11b-
deficient cells and wild-type DN2b cells were more spread out (K-S two-sided test; p = 
4.18e-22).  
D. Hierarchical clustering of expression patterns of 1,746 differentially expressed genes. 
Expression levels of differentially expressed genes are hierarchically clustered along both 
sample and gene dimensions and displayed as a heatmap. A subcluster representing the 
most changed genes is zoomed in to highlight the distinct patterns. 
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Figure 2. Distinct patterns of differentially expressed genes in Bcl11b-deficient cells. 
A. K-means clustering for differentially expressed genes. 1,746 differentially expressed 
genes were subjected to K-means clustering analysis. The number of genes in each 
cluster is included in each parenthesis. Genes in each cluster are listed in order in Table 
S1. 
B. Some known early T-cell development related genes were selected from each of four 
subgroups, and plotted accordingly. Colored bars represent the level (bar length) and 
direction (bar color) of change in mRNA expression for individual genes. Light blue 
indicates downregulation from DN2a to Bcl11b-deficient DN2a; red indicates 
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upregulation from DN2a to Bcl11b-deficient DN2a; light brown indicates 
downregulation from Bcl11b-deficient DN2a to DN2b; and navy blue indicates 
upregulation from Bcl11b-deficient DN2a to DN2b. Dashed lines are the boundaries for 
≥2x change in expression.  
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Figure 3. Bcl11b deletion leads to changes in Notch1 and Gata3 expression, but not 
pro-T cell identity. 
A. UCSC genome browser track image depicting expression pattern at Notch1 locus.  
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B. UCSC genome browser track image depicting expression pattern (top three) and 
GATA-3 occupancy (bottom 2) at Gata3 locus.  
Order from top to bottom: RNA-seq of Bcl11b+/+DN2a, Bcl11b-/-DN2a and 
Bcl11b+/+DN2b, and ChIP-seq of Bcl11b-/-DN2a and Bcl11b+/+DN2b. Red arrow: TSS 
and direction of transcription. Uniform scales are used for mRNA or ChIP in all cell 
types, as shown by y-axis labels (RPKM for RNA-seq, RPM for ChIP-seq). 
Chromosomal coordinates are indicated below each panel. 
C. Scatter plots depicting the comparisons in GATA-3 binding between Bcl11b-deficient 
DN2a with wild-type DN1, DN2b or DP. Pearson correlation coefficients are shown for 
each comparison. 
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Figure S1. GATA3 targets that are specifically upregulated in Bcl11b-deficient 
DN2a cells.  
A-F. UCSC genome browser track image depicting expression pattern (top three) and 
GATA-3 occupancy (bottom 2) at selected GATA-3 targets gene loci that are specifically 
upregulated in Bcl11b-deficient DN2a cells: Id2, Zbtb16, Il2rb, Cpa3, Ikzf2 and Zbtb7b. 
Order from top to bottom: RNA-seq of Bcl11b+/+DN2a, Bcl11b-/-DN2a and 
Bcl11b+/+DN2b, and ChIP-seq of Bcl11b-/-DN2a and Bcl11b+/+DN2b. Red arrow: TSS 
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and direction of transcription. Uniform scales are used for ChIP in all cell types, and 
mRNA scales are uniform within each panel, as shown by y-axis labels (RPKM for 
RNA-seq, RPM for ChIP-seq). Chromosomal coordinates are indicated below each panel. 
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Supplementary Tables 1-2  
Table S1. K-means clustering for differentially expressed genes in Bcl11b-deficient 
DN2a compared to wild-type cells (see supplementary files). 
Table S2. Genome-wide GATA3 binding in Bcl11b-deficient DN2a (see supplementary 
files). 
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The purpose of my thesis is to study the molecular mechanism underlying T-cell 
lineage specification and commitment. Using genome-wide sequencing and proper 
statistical analysis tools, we mapped and analyzed the global distributions and 
longitudinal changing patterns of histone modifications, the correlated transcriptional 
activities, as well as the occupancies of two transcription factors, PU.1 and GATA-3, in 
five successive stages of early T-cell development. Our results delineate mechanistically 
separated and sequentially occurred downregulation as well as upregulation events during 
the critical T-lineage commitment process, which help explain why there is not a single 
“master” regulator that dictates the whole process. Our data also provide a 
comprehensive resource of discrete histone-modified genomic regions, some of which 
have been utilized in a stage-specific manner and may define at least partially the 
regulatory network during early T-cell development. Furthermore, combining this global 
approach with gene perturbation, we investigated the function of Bcl11b, a T-cell specific 
regulator, on T-lineage commitment. The gene expression profiling and GATA-3 global 
occupancy analysis in Bcl11b-deficent cells indicate that Bcl11b is required for the 
proper expression of Notch1, Notch3 and Gata3 during this process, and the 
cooperatively interplay between Bcl11b, Notch and GATA-3 is essential for the 
completion of T-cell lineage specification and the elimination of NK lineage potential. 
On the other hand, from our genome-wide studies several interesting questions 
have emerged, and are worth for further exploration. 
H3K27me3 vs. H3K9me3 and DNA Methylation 
A major feature linked to T-lineage commitment is the gradual repression of 
progenitor-associated genes. In Chapter 2, we found a series of progressive epigenetic 
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changes in establish a stable repressive chromatin structure at some newly repressed gene 
loci, including promoter regions and/or distal elements. The likely epigenetic event that 
initiates repression process is the gradual deacetylation, which often slightly precedes or 
is parallel with the downregulation of mRNA expression. The reduction in H3K4me2 
enrichment usually delays one or two developmental stages compared to that in H3Ac 
and mRNA, sometimes being accompanied by focal then slowly expanded H3K27me3 
enrichment. But at some gene loci H3K27me3 is not on until the genes are completely or 
almost completely silent. These observations indicate that while relinquishing of active 
epigenetic modification is the default method for gene silencing, additional H3K27me3 
may act as a stabilizer for the repression. Presumably, this added epigenetic repression 
reduces the likelihood of escaping gene silencing and lineage reprogramming. 
On the other hand, however, while silent transcription factors are specifically 
favored by H3K27me3, only one third of all silent gene loci and even lower fraction of 
constitutively silent nonhematopoietic genes are enriched with H3K27me3 in any 
particular stage. Besides H3K27me3, H3K9me3 and DNA methylation are also 
implicated in the developmentally regulated gene repression (Hawkins et al., 2010; Ji et 
al., 2010). It is reasonable to believe these two modifications may provide stable 
epigenetic repression for some silent gene loci that are not enriched with H3K27me3.  
H3K27me3 and H3K9me3 have been shown to selectively target different sets of 
genes in human embryonic stem cells (hESCs) as well as the terminal differentiated fetal 
lung fibroblasts (IMR90) with very small percentage of overlapping (Hawkins et al., 
2010). And both modifications are associated with lineage and/or developmentally 
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related genes in hESCs, and with nondevelopmentally related genes in IMR90 (Hawkins 
et al., 2010).  
DNA methylation represses gene expression by methylating promoter CpG 
islands, and developmentally programmed CpG methylation is associated with lineage 
restriction (Ji et al., 2010). Interestingly, in one study that compares DNA methylation 
pattern with different histone modification patterns, while most active promoters are 
hypomethylated, a subset of silent promoters that lack any histone modifications are 
hypermethylated (Hawkins et al., 2010). Since DNA methylation is believed to be less 
flexible than histone modifications, and can be maintained during cell division, it may 
provide long-term lineage stability when initial factors required for silencing are no 
longer present (Cedar and Bergman, 2011).  
Possible Roles of Zbtb7b and Bcl11a in the Absence of Bcl11b 
In Chapter 3, we found a group of about 50 genes that were both upregulated 
specifically in Bcl11b-deficient DN2a cell and bound by GATA-3. Gata3 itself is among 
this group. Since three genes from this group, Zbtb16, Id2 and IL2rb, are strongly 
connected to the enhanced NK-potential in response to Bcl11b deletion, this finding 
implies the potential NK-lineage promoting function of GATA-3 in the absence of 
Bcl11b.  
Another gene that also belongs to this group is Zbtb7b. Zbtb7b (or Thpok) is a 
CD4 T cell lineage-specific regulator. The sequential activity of GATA-3 and Zbtb7b 
leads DP cells into CD4 SP (single positive) pathway (Wang et al., 2008). Thpok 
deficiency abolishes CD4 T cell development, and directs DP cells into CD8 lineage 
without affecting positive selection (Kappes, 2010). However, it is unclear whether 
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Zbtb7b plays any role in early T-cell development (in particular,  αβ T cell) prior to 
positive selection. 
Our genome-wide studies show that Zbtb7b is expressed at low level in DN1 
cells, and immediately diminished to essentially undetectable in DN2a and onward until 
the positive selection. Zbtb7b is actively repressed by H3K27me3 from DN2a to pre-
positive selection DP cells, though is also constitutively bound by GATA-3 throughout 
early T-cell development (see Chapter 2). GATA-3 has been shown to be a direct inducer 
of Zbtb7b during positive selection (Wang et al., 2008). The upregulation of Zbtb7b 
might be just a byproduct of increased GATA-3 with no negative effect, which is 
supported by the absence of Cd4 expression in Bcl11b-deficient DN2a cells. Or, the 
presence of Zbtb7b actually contributes to the overall phenotype of Bcl11b-deficient cells 
that is unrelated with CD4 SP development.  
Interestingly, recent studies show that the GATA-3 and Zbtb7b cascade is 
required in producing CD4+ CD1d-restricted invariant NKT (iNKT) cell development 
(Engel et al., 2010; Wang et al., 2010). Furthermore, Zbtb7b is highly expressed in 
NK1.1+ γδ T cell, implying a potential role in γδ T cell maturation and function (Kappes, 
2010). Collectively, these findings suggest Zbtb7b is not confined to solely promoting 
CD4 SP lineage differentiation.   
So, why do Bcl11b-deficient DN2a cells not express CD4? The most likely 
explanation is the presence of Runx3 in Bcl11b-deficient DN2a (see Chapter 2). Runx3 is 
a known repressor of CD4 expression (Collins et al., 2009).  Since Runx3 expression is 
not affected with the deletion of Bcl11b (see Chapter 3), it is possible that the amount of 
Zbtb7b in Bcl11b-deficient DN2a cells is unable to overpower Runx3 and activate CD4 
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expression. Although more experiments are needed, it should not be ruled out that Zbtb7b 
plays a possible role in Bcl11b-deficient DN2a specific phenotypes, which, if is true, may 
highlight the importance of the programmed epigenetic repression at Zbtb7b locus during 
normal T-lineage commitment.   
Another remaining question worth to be addressed in the future is why Bcl11b 
deletion leads to the upregulation of some genes that are not expressed or expressed at 
low or background levels in pro-T cell (DN1, or DN2a, or both), such as Zbtb7b and 
Il2rb. Since Bcl11b is not expressed in DN1 cells, and expressed at modest level in DN2a 
cells, there must be additional mechanism(s), i.e., a specific regulator equivalent to 
Bcl11b. One candidate is Bcl11a, a paralog of Bcl11b (Avram et al., 2000; Avram et al., 
2002).  
Bcl11a is an essential B-lineage regulator and plays a key role in promoting fetal-
to-adult switch in hemoglobin expression (Liu et al., 2003; Sankaran et al., 2010). Bcl11a 
is expressed in DN1 cell, and gradually downregulated afterward until being completely 
turned off during DN2b to DN3 transition. And it is one of the “intermediate” genes 
whose expression levels in Bcl11b-deficient DN2a cells lie in somewhere between those 
in DN2a and DN3a (see Chapter 3).    
Bcl11a and Bcl11b share a high percentage of amino acid sequence similarity, in 
particular the two centrally located zinc fingers, zinc finger 3 and 4 (94% identity) 
(Avram et al., 2002). It is reasonable to predict that the two transcription factors overlap 
in their binding targets. Intriguingly, in Bcl11a mutant fetal thymus, the number of γδT 
cells increases 3~4 fold while αβT cells are reduced compared to those in the wild-type 
control (Liu et al., 2003). The unique complement expression pattern of Bcl11a and 
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Bcl11b and the perturbation study results strongly suggest a functional connection 
between these two factors in early T-cell development. 
A Potential Stage-Specific Cis-regulatory Element of Gata3  
One of the major contributions from our genomic study is having identified 
~20,000 histone modified potential cis-regulatory elements (distal) that might be part of 
the gene network regulating early T-cell development. A number of previously identified 
cis-regulatory elements are among this list (see Chapter 2). 
  
 
Figure1. Schematic representation of Gata3 locus.  
The two isoforms of Gata3 utilize either exon1a (E1a, in red) or exon1b (E1b, in black). 
Exon1a and its flanking regions are enriched with H3K27me3 (indicated by two dark 
arrows) in DN and DP cells. One CSL DNA-binding site (CSL site) resides just upstream 
of exon1a, being buried by the H3K27me3 enrichment in DN and DP cells. Arrows on 
the top indicate the directions of transcription. Filled boxes are the translated regions 
 
In Chapter 3, we found that the elevated GATA-3 expression may mediate at least 
partially the phenotypic defect caused by Bcl11b deletion. And as opposite to its essential 
role in early T-cell development at the normal level, high dosage of GATA-3 has 
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previously shown to divert pro-T into mast cell lineage (Taghon et al., 2007). In sharp 
contrast, overexpression of GATA-3 in CD4 naïve or Th1 cells is able to promote Th2 
differentiation (Ouyang et al., 1998; Ouyang et al., 2000). 
GATA3 utilizes an alternative promoter in a stage-specific manner. While both 
distal E1a (exon 1a) and proximal E1b (exon 1b) are expressed in Th2 cells, the isoform 
containing the proximal E1b is the predominate form in thymocytes (Asnagli et al., 2002) 
(Figure 1). GATA-3 (E1b isoform) is among the earliest factors induced by Notch-Delta 
signaling (Taghon et al., 2005), suggesting Gata3 is a downstream target of Notch-Delta 
signaling. However, the distal E1a promoter can be upregulated by Notch1 in Th2 cells 
but not in thymocytes (Amsen et al., 2007; Fang et al., 2007). It is unclear why the E1a 
promoter does not response to Notch-Delta signaling in these early T cells. Nevertheless, 
these data suggest there is a cell-intrinsic inhibitory mechanism in play to restrain 
GATA-3 from inappropriate upregulation by Notch signaling. Our genome-wide studies 
demonstrate that as no or very few transcripts are generated from the distal E1a in all five 
populations, the region spanning from the upstream of E1a promoter, which includes a 
known CSL binding site, to the downstream intronic region between E1a and E1b is 
correspondingly heavily covered with H3K27me3 (see Chapter 2). Within this region, a 
smaller distinct island just upstream of the E1a TSS (transcription start site) was enriched 
with both H3K4me2 and H3K27me3, but low for H3Ac, suggesting that the E1a 
promoter is already “poised” for activation as early as in DN1 stage.  Interestingly, the 
H3K27me3 enrichment is retained across this region in CD4 naïve T cell, and abolished 
in Th2 cells where E1a is upregulated (Wei et al., 2009).  Our data indicate that during 
early T-cell development, the widespread distal H3K27me3 prevents the E1a promoter 
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from being activated, resulting in a tightly controlled expression of GATA-3. And more 
importantly, there might actually be a potential repressor element(s) masked with 
H3K27me3 enrichment within this region. 
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